S-1 1 forms-1.htm
0001156784 false false 0001156784 2022-01-01 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesAMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesAMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesBMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesBMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesCMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesCMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesDMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesDMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesEMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesEMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesFMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesFMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesGMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:RedeemablePreferredStockSeriesGMember 2021-12-31 0001156784 2021-12-31 0001156784 2020-12-31 0001156784 us-gaap:RedeemablePreferredStockMember 2021-12-31 0001156784 us-gaap:RedeemablePreferredStockMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesCMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesCMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesAMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesAMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 2021-01-01 2021-12-31 0001156784 2020-01-01 2020-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001156784 us-gaap:CommonStockMember 2019-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001156784 us-gaap:TreasuryStockMember 2019-12-31 0001156784 us-gaap:RetainedEarningsMember 2019-12-31 0001156784 2019-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember us-gaap:PreferredStockMember 2019-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember us-gaap:PreferredStockMember 2019-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember us-gaap:PreferredStockMember 2019-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember us-gaap:PreferredStockMember 2019-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember us-gaap:PreferredStockMember 2019-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001156784 us-gaap:CommonStockMember 2020-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001156784 us-gaap:TreasuryStockMember 2020-12-31 0001156784 us-gaap:RetainedEarningsMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember us-gaap:PreferredStockMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember us-gaap:PreferredStockMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember us-gaap:PreferredStockMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember us-gaap:PreferredStockMember 2020-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember us-gaap:PreferredStockMember 2020-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001156784 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001156784 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:AdditionalPaidInCapitalMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:RetainedEarningsMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesBMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesDMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesEMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesFMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:PreferredStockMember COWI:RedeemablePreferredStockSeriesGMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 us-gaap:RedeemablePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001156784 us-gaap:CommonStockMember 2021-12-31 0001156784 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001156784 us-gaap:TreasuryStockMember 2021-12-31 0001156784 us-gaap:RetainedEarningsMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesBMember us-gaap:PreferredStockMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesDMember us-gaap:PreferredStockMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesEMember us-gaap:PreferredStockMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesFMember us-gaap:PreferredStockMember 2021-12-31 0001156784 COWI:RedeemablePreferredStockSeriesGMember us-gaap:PreferredStockMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:CoroWareTechnologiesIncMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:LicenseAgreementTermsMember COWI:CorowareIncAndSubsidiariesMember 2021-06-01 2021-06-02 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:LicenseMember COWI:CorowareIncAndSubsidiariesMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:LicenseMember srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember srt:AmericasMember COWI:CorowareIncAndSubsidiariesMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember us-gaap:EuropeanUnionMember COWI:CorowareIncAndSubsidiariesMember 2021-06-01 2021-06-02 0001156784 COWI:LicenseOfAgreementMember COWI:CorowareIncAndSubsidiariesMember 2021-12-01 2021-12-02 0001156784 COWI:LicenseOfAgreementMember COWI:CorowareIncAndSubsidiariesMember 2022-02-01 2022-02-17 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-02-01 2022-02-17 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-02-17 0001156784 COWI:LicenseOneMember COWI:CorowareIncAndSubsidiariesMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseThreeMember COWI:CorowareIncAndSubsidiariesMember 2022-02-01 2022-02-17 0001156784 us-gaap:LicenseAgreementTermsMember 2021-10-30 2021-10-31 0001156784 us-gaap:LicenseAgreementTermsMember 2021-06-01 2021-06-02 0001156784 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:LicenseMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:LicenseMember srt:MaximumMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember srt:AmericasMember 2021-06-01 2021-06-02 0001156784 us-gaap:LicenseAgreementTermsMember us-gaap:PatentsMember us-gaap:EuropeanUnionMember 2021-06-01 2021-06-02 0001156784 COWI:LicenseOfAgreementMember 2021-12-01 2021-12-02 0001156784 COWI:LicenseOfAgreementMember 2022-02-01 2022-02-17 0001156784 2022-02-01 2022-02-17 0001156784 COWI:LicenseOneMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseTwoMember 2022-02-01 2022-02-17 0001156784 COWI:LicenseThreeMember 2022-02-01 2022-02-17 0001156784 COWI:AriconLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:FurnitureAndFixturesMember srt:MinimumMember us-gaap:LicenseMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:FurnitureAndFixturesMember srt:MinimumMember COWI:LicenseOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesBPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesBPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:FurnitureAndFixturesMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:ComputerEquipmentMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001156784 COWI:FilamentProductionEquipmentMember srt:MaximumMember 2021-01-01 2021-12-31 0001156784 us-gaap:FairValueInputsLevel1Member COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:FairValueInputsLevel2Member COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:FairValueInputsLevel3Member COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:FairValueInputsLevel1Member COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:FairValueInputsLevel2Member COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:FairValueInputsLevel3Member COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001156784 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001156784 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001156784 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001156784 us-gaap:FairValueInputsLevel2Member 2020-12-31 0001156784 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:LicenseOneMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:LicenseOneMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:LicenseTwoMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:LicenseTwoMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-10-28 0001156784 COWI:CorowareIncAndSubsidiariesMember 2021-10-01 2021-10-28 0001156784 2021-10-28 0001156784 2021-10-01 2021-10-28 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:CarbonMetaTechnologiesIncMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:CoroWareTechnologiesIncMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:CoroWareRoboticsSolutionsIncMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:CarbonSourceIncMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:AriconLlcMember 2022-03-31 0001156784 COWI:CarbonMetaTechnologiesIncMember 2021-12-31 0001156784 COWI:CoroWareTechnologiesIncMember 2021-12-31 0001156784 COWI:CoroWareRoboticsSolutionsIncMember 2021-12-31 0001156784 COWI:CoroWareTreasuryIncMember 2021-12-31 0001156784 COWI:AriconLlcMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:QuickFixCapitalArrangementMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:QuickFixCapitalArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpArrangementMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpOneArrangementMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpOneArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpTwoArrangementMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpTwoArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpThreeArrangementMember 2022-03-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpThreeArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:KnightCapitalArrangementMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:KnightCapitalArrangementMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:QuickFixCapitalArrangementMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpArrangementMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpOneArrangementMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpTwoArrangementMember 2020-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember COWI:PowerUpThreeArrangementMember 2020-12-31 0001156784 COWI:KnightCapitalArrangementMember 2021-12-31 0001156784 COWI:KnightCapitalArrangementMember 2020-12-31 0001156784 COWI:QuickFixCapitalArrangementMember 2021-12-31 0001156784 COWI:QuickFixCapitalArrangementMember 2020-12-31 0001156784 COWI:PowerUpArrangementMember 2021-12-31 0001156784 COWI:PowerUpArrangementMember 2020-12-31 0001156784 COWI:PowerUpOneArrangementMember 2021-12-31 0001156784 COWI:PowerUpOneArrangementMember 2020-12-31 0001156784 COWI:PowerUpTwoArrangementMember 2021-12-31 0001156784 COWI:PowerUpTwoArrangementMember 2020-12-31 0001156784 COWI:PowerUpThreeArrangementMember 2021-12-31 0001156784 COWI:PowerUpThreeArrangementMember 2020-12-31 0001156784 COWI:PowerUpCapitalThreeMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCFourMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupFourMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupFiveMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupFiveMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCSixMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:LloydTSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:LloydTSpencerMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:LloydTSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LloydTSpencerMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:DakotaMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:DakotaMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:DakotaMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:ZoomMarketingMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:ZoomMarketingMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:ZoomMarketingMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BurringtonCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:BurringtonCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-03-31 0001156784 COWI:BurringtonCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:BurringtonCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:PatrickFerroMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:PatrickFerroMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:PatrickFerroMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:PatrickFerroMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BarryLibenMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:BarryLibenMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:BarryLibenMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:BarryLibenMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:JaredRobertMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:JaredRobertMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:JaredRobertMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:JaredRobertMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RaphaelCariouMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RaphaelCariouMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RaphaelCariouMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RaphaelCariouOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RaphaelCariouOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RaphaelCariouOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RaphaelCariouTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RaphaelCariouTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RaphaelCariouTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RedwoodManagementLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RedwoodManagementLlcMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RedwoodManagementLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RedwoodManagementLlcMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:AgsCapitalGroupLlcMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:AgsCapitalGroupLlcMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:AgsCapitalGroupLlcOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:AgsCapitalGroupLlcOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:TimBurgessMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TimBurgessMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:TimBurgessMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TimBurgessMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:AzrielNagarMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:AzrielNagarMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:AzrielNagarMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:AzrielNagarMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:KelburghLtdMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:KelburghLtdMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:KelburghLtdMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:KelburghLtdMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:PremierItSolutionsMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:PremierItSolutionsMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:PremierItSolutionsMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:PremierItSolutionsMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:LGCapitalFundingLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LGCapitalFundingLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:LGCapitalFundingLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LGCapitalFundingLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:LGCapitalFundingLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LGCapitalFundingLLCTwoMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:BarclayLyonsMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:BlackridgeCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:BlackridgeCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:BlackridgeCapitalLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:BlackridgeCapitalLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:JulianHerskowitzMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:JulianHerskowitzMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:JulianHerskowitzMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:JulianHerskowitzMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:PatrickTuohyMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:PatrickTuohyMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:PatrickTuohyMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:PatrickTuohyMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2020-12-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RichardWynnsMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:RichardWynnsOneMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:RichardWynnsOneMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 COWI:RichardWynnsOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RichardWynnsOneMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 COWI:TAGlobalMember 2021-12-31 0001156784 COWI:TAGlobalMember 2020-12-31 0001156784 COWI:TAGlobalMember 2021-01-01 2021-12-31 0001156784 COWI:TAGlobalMember 2020-01-01 2020-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2021-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2020-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2021-01-01 2021-12-31 0001156784 COWI:WestmountHoldingsInternationalLtdMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember 2020-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:LoanDateMarchNineTwoThousandThirteenAndDueDateMarchNineTwoThousandFourteenMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersOneMember 2021-12-31 0001156784 COWI:TangiersOneMember 2020-12-31 0001156784 COWI:TangiersOneMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersOneMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersAssignedFromZoomMember 2021-12-31 0001156784 COWI:TangiersAssignedFromZoomMember 2020-12-31 0001156784 COWI:TangiersAssignedFromZoomMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersAssignedFromZoomMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersTwoMember 2021-12-31 0001156784 COWI:TangiersTwoMember 2020-12-31 0001156784 COWI:TangiersTwoMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersTwoMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersThreeMember 2021-12-31 0001156784 COWI:TangiersThreeMember 2020-12-31 0001156784 COWI:TangiersThreeMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersThreeMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersFourMember 2021-12-31 0001156784 COWI:TangiersFourMember 2020-12-31 0001156784 COWI:TangiersFourMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersFourMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersInvestmentGroupMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupMember 2020-12-31 0001156784 COWI:TangiersInvestmentGroupMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupMember 2020-01-01 2020-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember 2021-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember 2020-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember 2021-01-01 2021-12-31 0001156784 COWI:TangiersInvestmentGroupFiveMember 2020-01-01 2020-12-31 0001156784 COWI:DakotaMember 2021-12-31 0001156784 COWI:DakotaMember 2020-12-31 0001156784 COWI:DakotaMember 2021-01-01 2021-12-31 0001156784 COWI:DakotaMember 2020-01-01 2020-12-31 0001156784 COWI:ZoomMarketingMember 2013-08-01 2013-08-23 0001156784 COWI:ZoomMarketingMember 2021-12-31 0001156784 COWI:ZoomMarketingMember 2020-12-31 0001156784 COWI:ZoomMarketingMember 2021-01-01 2021-12-31 0001156784 COWI:ZoomMarketingMember 2020-01-01 2020-12-31 0001156784 COWI:BurlingtonCapitalLLCMember 2014-04-01 2014-04-02 0001156784 COWI:BurringtonCapitalLLCMember 2021-12-31 0001156784 COWI:BurringtonCapitalLLCMember 2020-12-31 0001156784 COWI:BurringtonCapitalLLCMember 2021-01-01 2021-12-31 0001156784 COWI:BurringtonCapitalLLCMember 2020-01-01 2020-12-31 0001156784 COWI:PatrickFerroMember 2021-12-31 0001156784 COWI:PatrickFerroMember 2020-12-31 0001156784 COWI:PatrickFerroMember 2021-01-01 2021-12-31 0001156784 COWI:PatrickFerroMember 2020-01-01 2020-12-31 0001156784 COWI:BarryLibenMember 2021-12-31 0001156784 COWI:BarryLibenMember 2020-12-31 0001156784 COWI:BarryLibenMember 2021-01-01 2021-12-31 0001156784 COWI:BarryLibenMember 2020-01-01 2020-12-31 0001156784 COWI:JaredRobertMember 2014-12-01 2014-12-10 0001156784 COWI:JaredRobertMember 2021-12-31 0001156784 COWI:JaredRobertMember 2020-12-31 0001156784 COWI:JaredRobertMember 2021-01-01 2021-12-31 0001156784 COWI:JaredRobertMember 2020-01-01 2020-12-31 0001156784 COWI:RaphaelCariouMember 2021-12-31 0001156784 COWI:RaphaelCariouMember 2020-12-31 0001156784 COWI:RaphaelCariouMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouMember 2020-01-01 2020-12-31 0001156784 COWI:RaphaelCariouOneMember 2021-12-31 0001156784 COWI:RaphaelCariouOneMember 2020-12-31 0001156784 COWI:RaphaelCariouOneMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouOneMember 2020-01-01 2020-12-31 0001156784 COWI:RaphaelCariouTwoMember 2021-12-31 0001156784 COWI:RaphaelCariouTwoMember 2020-12-31 0001156784 COWI:RaphaelCariouTwoMember 2021-01-01 2021-12-31 0001156784 COWI:RaphaelCariouTwoMember 2020-01-01 2020-12-31 0001156784 COWI:RedwoodManagementLlcMember 2021-12-31 0001156784 COWI:RedwoodManagementLlcMember 2020-12-31 0001156784 COWI:RedwoodManagementLlcMember 2021-01-01 2021-12-31 0001156784 COWI:RedwoodManagementLlcMember 2020-01-01 2020-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2020-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2021-01-01 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcMember 2020-01-01 2020-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2020-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2021-01-01 2021-12-31 0001156784 COWI:AgsCapitalGroupLlcOneMember 2020-01-01 2020-12-31 0001156784 COWI:TimBurgessMember 2021-12-31 0001156784 COWI:TimBurgessMember 2020-12-31 0001156784 COWI:TimBurgessMember 2021-01-01 2021-12-31 0001156784 COWI:TimBurgessMember 2020-01-01 2020-12-31 0001156784 COWI:AzrielNagarMember 2021-12-31 0001156784 COWI:AzrielNagarMember 2020-12-31 0001156784 COWI:AzrielNagarMember 2021-01-01 2021-12-31 0001156784 COWI:AzrielNagarMember 2020-01-01 2020-12-31 0001156784 COWI:KelburghLtdMember 2021-12-31 0001156784 COWI:KelburghLtdMember 2020-12-31 0001156784 COWI:KelburghLtdMember 2021-01-01 2021-12-31 0001156784 COWI:KelburghLtdMember 2020-01-01 2020-12-31 0001156784 COWI:PremierItSolutionsMember 2021-12-31 0001156784 COWI:PremierItSolutionsMember 2020-12-31 0001156784 COWI:PremierItSolutionsMember 2021-01-01 2021-12-31 0001156784 COWI:PremierItSolutionsMember 2020-01-01 2020-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2020-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCMember 2020-01-01 2020-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2020-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCOneMember 2020-01-01 2020-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2021-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2020-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2021-01-01 2021-12-31 0001156784 COWI:LGCapitalFundingLLCTwoMember 2020-01-01 2020-12-31 0001156784 COWI:BarclayLyonsMember 2011-01-28 2011-01-28 0001156784 COWI:BarclayLyonsMember 2021-12-31 0001156784 COWI:BarclayLyonsMember 2020-12-31 0001156784 COWI:BarclayLyonsMember 2021-01-01 2021-12-31 0001156784 COWI:BarclayLyonsMember 2020-01-01 2020-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2020-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2021-01-01 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCMember 2020-01-01 2020-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2020-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2021-01-01 2021-12-31 0001156784 COWI:BlackridgeCapitalLLCOneMember 2020-01-01 2020-12-31 0001156784 COWI:RBBCapitalLLCMember 2011-06-02 2011-06-02 0001156784 COWI:RBBCapitalLLCMember 2021-12-31 0001156784 COWI:RBBCapitalLLCMember 2020-12-31 0001156784 COWI:RBBCapitalLLCMember 2021-01-01 2021-12-31 0001156784 COWI:RBBCapitalLLCMember 2020-01-01 2020-12-31 0001156784 COWI:RBBCapitalLLCOneMember 2011-06-29 2011-06-29 0001156784 COWI:RBBCapitalLLCOneMember 2021-12-31 0001156784 COWI:RBBCapitalLLCOneMember 2020-12-31 0001156784 COWI:RBBCapitalLLCOneMember 2021-01-01 2021-12-31 0001156784 COWI:RBBCapitalLLCOneMember 2020-01-01 2020-12-31 0001156784 COWI:JulianHerskowitzMember 2021-12-31 0001156784 COWI:JulianHerskowitzMember 2020-12-31 0001156784 COWI:JulianHerskowitzMember 2021-01-01 2021-12-31 0001156784 COWI:JulianHerskowitzMember 2020-01-01 2020-12-31 0001156784 COWI:PatrickTuohyMember 2021-12-31 0001156784 COWI:PatrickTuohyMember 2020-12-31 0001156784 COWI:PatrickTuohyMember 2021-01-01 2021-12-31 0001156784 COWI:PatrickTuohyMember 2020-01-01 2020-12-31 0001156784 COWI:RichardWynnsMember 2021-12-31 0001156784 COWI:RichardWynnsMember 2020-12-31 0001156784 COWI:RichardWynnsMember 2021-01-01 2021-12-31 0001156784 COWI:RichardWynnsMember 2020-01-01 2020-12-31 0001156784 COWI:RichardWynnsOneMember 2021-12-31 0001156784 COWI:RichardWynnsOneMember 2020-12-31 0001156784 COWI:RichardWynnsOneMember 2021-01-01 2021-12-31 0001156784 COWI:RichardWynnsOneMember 2020-01-01 2020-12-31 0001156784 COWI:RBBCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:RBBCapitalLLCOneMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TAGlobalMember 2016-02-01 2016-02-05 0001156784 COWI:TangiersOneMember 2013-11-01 2013-11-13 0001156784 COWI:TangiersOneMember 2014-03-27 2014-03-27 0001156784 COWI:TangiersThreeMember 2016-10-01 2016-10-11 0001156784 COWI:TangiersFourMember 2017-01-01 2017-01-30 0001156784 COWI:TangiersInvestmentGroupMember 2021-07-01 2021-07-19 0001156784 COWI:TangiersInvestmentGroupMember 2021-08-01 2021-08-08 0001156784 COWI:DakotaMember 2014-04-01 2014-04-08 0001156784 COWI:PatrickFerroMember 2014-04-01 2014-04-03 0001156784 COWI:BarryLibenMember 2014-04-01 2014-04-03 0001156784 COWI:RaphaelCariouMember 2012-08-01 2012-08-03 0001156784 COWI:RaphaelCariouOneMember 2015-03-12 2015-03-12 0001156784 COWI:RaphaelCariouTwoMember 2015-03-12 2015-03-12 0001156784 COWI:RedwoodManagementLlcMember 2011-03-21 2011-03-21 0001156784 COWI:AgsCapitalGroupLlcMember 2013-02-25 2013-03-25 0001156784 COWI:TimBurgessMember 2003-07-08 2003-07-08 0001156784 COWI:AzrielNagarMember 2003-07-08 2003-07-08 0001156784 COWI:KelburghLtdMember 2012-02-12 2012-02-12 0001156784 COWI:PremierItSolutionsMember 2011-10-05 2011-10-05 0001156784 COWI:LGCapitalFundingLLCMember 2014-03-11 2014-03-11 0001156784 COWI:LGCapitalFundingLLCOneMember 2015-01-07 2015-01-07 0001156784 COWI:LGCapitalFundingLLCTwoMember 2014-03-11 2014-03-11 0001156784 COWI:BlackridgeCapitalLLCMember 2011-04-02 2011-04-02 0001156784 COWI:BlackridgeCapitalLLCOneMember 2014-02-21 2014-02-21 0001156784 COWI:RichardWynnsMember 2005-07-22 2005-07-22 0001156784 COWI:RichardWynnsOneMember 2010-07-26 2010-07-26 0001156784 COWI:RaphaelCariouMember 2014-04-01 2014-04-08 0001156784 COWI:RichardWynnsOneMember 2014-04-01 2014-04-08 0001156784 COWI:BarclayLyonsMember 2014-04-01 2014-04-08 0001156784 COWI:BlackridgeCapitalLLCMember 2014-04-01 2014-04-08 0001156784 COWI:KelburghLtdMember 2014-04-01 2014-04-08 0001156784 COWI:AgsCapitalGroupLlcOneMember 2014-04-01 2014-04-08 0001156784 COWI:BlackridgeCapitalLLCOneMember 2014-04-01 2014-04-08 0001156784 COWI:LGCapitalFundingLLCTwoMember 2014-04-01 2014-04-08 0001156784 COWI:JaredRobertMember 2014-04-01 2014-04-08 0001156784 COWI:BarryLibenMember 2014-04-01 2014-04-08 0001156784 2014-04-01 2014-04-08 0001156784 COWI:RBBCapitalLLCMember 2014-04-01 2014-04-08 0001156784 COWI:RBBCapitalLLCOneMember 2014-04-01 2014-04-08 0001156784 COWI:JulianHerskowitzMember 2014-04-01 2014-04-08 0001156784 COWI:YaGlobalInvestmentsLpMember COWI:SettlementAgreementMember 2021-09-24 2021-10-13 0001156784 COWI:YaGlobalInvestmentsLpMember COWI:SettlementAgreementMember 2021-10-13 0001156784 COWI:NotePayableOneMember 2021-12-31 0001156784 COWI:NotePayableOneMember 2020-12-31 0001156784 COWI:NotePayableTwoMember 2021-12-31 0001156784 COWI:NotePayableTwoMember 2020-12-31 0001156784 COWI:NotePayableThreeMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableThreeMember 2021-12-31 0001156784 COWI:NotePayableThreeMember 2020-12-31 0001156784 COWI:NotePayableFourMember 2021-12-31 0001156784 COWI:NotePayableFourMember 2020-12-31 0001156784 COWI:NotePayableFiveMember 2021-12-31 0001156784 COWI:NotePayableFiveMember 2020-12-31 0001156784 COWI:NotePayableSixMember 2021-12-31 0001156784 COWI:NotePayableSixMember 2020-12-31 0001156784 COWI:NotePayableSevenMember 2021-12-31 0001156784 COWI:NotePayableSevenMember 2020-12-31 0001156784 COWI:NotePayableEightMember 2021-12-31 0001156784 COWI:NotePayableEightMember 2020-12-31 0001156784 COWI:NotePayableNineMember 2021-12-31 0001156784 COWI:NotePayableNineMember 2020-12-31 0001156784 COWI:NotePayableTenMember 2021-12-31 0001156784 COWI:NotePayableTenMember 2020-12-31 0001156784 srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 srt:MinimumMember 2021-01-01 2021-12-31 0001156784 srt:MaximumMember 2021-01-01 2021-12-31 0001156784 srt:MinimumMember 2021-12-31 0001156784 srt:MaximumMember 2021-12-31 0001156784 COWI:CorowareIncAndSubsidiariesMember 2002-04-01 2002-04-17 0001156784 COWI:CorowareIncAndSubsidiariesMember 2002-04-17 0001156784 2002-04-01 2002-04-17 0001156784 2002-04-17 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember COWI:CorowareIncAndSubsidiariesMember 2022-12-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2020-12-31 0001156784 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2020-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2020-12-31 0001156784 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2020-12-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001156784 us-gaap:MeasurementInputExpectedDividendRateMember 2020-12-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001156784 us-gaap:MeasurementInputPriceVolatilityMember 2020-12-31 0001156784 srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-12-31 0001156784 COWI:BlackScholesMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 srt:MinimumMember COWI:CorowareIncAndSubsidiariesMember 2020-01-01 2020-12-31 0001156784 srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 COWI:BlackScholesMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesAPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesAPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesAPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesBPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesBPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesCPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesCPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesCPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesDPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesDPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesDPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesDPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesEPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesEPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesEPreferredStockMember us-gaap:CommonStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesEPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesEPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesFPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesFPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesFPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesFPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesGPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 us-gaap:SeriesGPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 us-gaap:SeriesGPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SeriesGPreferredStockMember COWI:CorowareIncAndSubsidiariesMember 2021-01-01 2021-03-31 0001156784 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesBPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesCPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesDPreferredStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:SeriesEPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesEPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesEPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesEPreferredStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:SeriesFPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesFPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesFPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesFPreferredStockMember 2020-01-01 2020-12-31 0001156784 us-gaap:SeriesGPreferredStockMember 2021-12-31 0001156784 us-gaap:SeriesGPreferredStockMember 2021-01-01 2021-12-31 0001156784 us-gaap:SeriesGPreferredStockMember 2020-12-31 0001156784 us-gaap:SeriesGPreferredStockMember 2020-01-01 2020-12-31 0001156784 srt:MaximumMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:SubsequentEventMember COWI:ConsultantMember COWI:MutualReleaseAndSettlementAgreementMember COWI:CorowareIncAndSubsidiariesMember 2022-01-17 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-01-17 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-01-18 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:InterimJointProductDevelopmentAndSalesRepresentationAgreementMember COWI:CorowareIncAndSubsidiariesMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:LlyodSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:CorowareIncAndSubsidiariesMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember srt:BoardOfDirectorsChairmanMember COWI:CorowareIncAndSubsidiariesMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:EcomenaLimitedMember COWI:CorowareIncAndSubsidiariesMember 2022-02-17 2022-02-17 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-03-06 2022-03-07 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-03-07 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-03-20 2022-03-21 0001156784 COWI:CorowareIncAndSubsidiariesMember 2022-03-21 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2021-12-31 0001156784 us-gaap:TreasuryStockMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:LloydSpencerMember 2021-05-09 2021-05-09 0001156784 COWI:LloydSpencerMember 2016-12-31 0001156784 COWI:LloydSpencerMember 2017-12-31 0001156784 COWI:LloydSpencerMember 2018-12-31 0001156784 COWI:LloydSpencerMember 2019-12-31 0001156784 COWI:LloydSpencerMember 2020-12-31 0001156784 us-gaap:CommonStockMember 2021-05-27 2021-05-28 0001156784 COWI:NoteOneMember 2021-05-27 2021-05-28 0001156784 COWI:NoteTwoMember 2021-05-27 2021-05-28 0001156784 2021-06-03 2021-06-04 0001156784 2021-08-10 2021-08-10 0001156784 2021-09-14 2021-09-14 0001156784 2021-09-24 2021-09-24 0001156784 2021-09-27 2021-09-27 0001156784 2021-10-07 2021-10-07 0001156784 2021-10-13 2021-10-13 0001156784 2021-10-21 2021-10-21 0001156784 2021-10-21 0001156784 2021-10-22 2021-10-22 0001156784 2021-10-22 0001156784 us-gaap:CommonStockMember 2021-10-22 2021-10-22 0001156784 us-gaap:CommonStockMember 2021-10-22 0001156784 2021-11-04 2021-11-04 0001156784 2021-11-04 0001156784 2021-11-10 2021-11-10 0001156784 2021-11-10 0001156784 2021-11-12 2021-11-12 0001156784 2021-11-12 0001156784 us-gaap:TreasuryStockMember 2021-12-31 0001156784 us-gaap:TreasuryStockMember 2020-12-31 0001156784 COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:TangiersInvestmentGroupLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-03-06 2022-03-07 0001156784 COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-03-06 2022-03-08 0001156784 COWI:LloydSpencerMember COWI:CorowareIncAndSubsidiariesMember 2022-03-07 0001156784 COWI:LloydSpencerMember COWI:TransactionTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:LloydSpencerMember COWI:TransactionTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2022-03-20 2022-03-21 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2022-03-21 0001156784 COWI:YaGlobalMember COWI:CorowareIncAndSubsidiariesMember 2022-03-21 0001156784 COWI:TangiersInvestmentGroupMember COWI:TransactionTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-03-31 0001156784 COWI:TangiersInvestmentGroupMember COWI:TransactionTwoMember COWI:CorowareIncAndSubsidiariesMember 2022-01-01 2022-03-31 0001156784 COWI:StandbyEquityCommitmentAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember COWI:CorowareIncAndSubsidiariesMember 2022-04-12 2022-04-14 0001156784 COWI:StandbyEquityCommitmentAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember COWI:CorowareIncAndSubsidiariesMember 2022-04-14 0001156784 COWI:TangiersInvestmentGroupMember COWI:CorowareIncAndSubsidiariesMember 2022-05-01 2022-05-10 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:HolderMember COWI:CorowareIncAndSubsidiariesMember 2022-05-08 2022-05-10 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:HolderMember COWI:CorowareIncAndSubsidiariesMember 2022-05-10 0001156784 us-gaap:SubsequentEventMember COWI:BHPCapitalNYIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:BHPCapitalNYIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:BHPCapitalNYIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember COWI:CorowareIncAndSubsidiariesMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember COWI:CorowareIncAndSubsidiariesMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember COWI:CorowareIncAndSubsidiariesMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-15 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember COWI:CorowareIncAndSubsidiariesMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:ConsultantMember COWI:MutualReleaseAndSettlementAgreementMember 2022-01-17 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:LloydSpencerMember 2022-01-17 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:LloydSpencerMember 2022-01-18 2022-01-21 0001156784 us-gaap:SubsequentEventMember COWI:InterimJointProductDevelopmentAndSalesRepresentationAgreementMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:LlyodSpencerMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:ThreeIndividualMember 2022-02-13 2022-02-14 0001156784 us-gaap:SubsequentEventMember COWI:EcomenaLimitedMember 2022-02-17 2022-02-17 0001156784 us-gaap:SubsequentEventMember 2022-02-01 2022-02-17 0001156784 2022-02-17 0001156784 us-gaap:SubsequentEventMember COWI:LloydTSpencerMember 2022-03-07 2022-03-07 0001156784 us-gaap:SubsequentEventMember COWI:LloydTSpencerMember 2022-03-07 0001156784 us-gaap:SubsequentEventMember COWI:TangiersInvestmentGroupLLCMember 2022-03-21 2022-03-21 0001156784 us-gaap:SubsequentEventMember COWI:TangiersInvestmentGroupLLCMember 2022-03-21 0001156784 COWI:StandbyEquityCommitmentAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember 2022-04-12 2022-04-14 0001156784 COWI:StandbyEquityCommitmentAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember 2022-04-14 0001156784 COWI:TangiersInvestmentGroupMember 2022-05-01 2022-05-10 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:HolderMember 2022-05-08 2022-05-10 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:HolderMember 2022-05-10 0001156784 us-gaap:SubsequentEventMember COWI:MacRabLLCMember 2022-05-10 0001156784 us-gaap:SubsequentEventMember COWI:BHPCapitalNYIncMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:BHPCapitalNYIncMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:QuickCapitalLLCMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember 2022-07-12 2022-07-14 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RobertPapiriDefinedBenefitPlanOneMember 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember 2022-07-12 2022-07-15 0001156784 COWI:FixedConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember 2022-07-12 2022-07-15 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember 2022-07-12 2022-07-14 0001156784 us-gaap:SubsequentEventMember COWI:RGPCapitalPartnersIncMember 2022-07-14 0001156784 COWI:NotePayableOneMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableTwoMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableFourMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableFiveMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableSixMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableSevenMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableEightMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableNineMember 2021-01-01 2021-12-31 0001156784 COWI:NotePayableTenMember 2021-01-01 2021-12-31 0001156784 COWI:StockPurchaseWarrantsMember 2021-12-31 0001156784 COWI:StockPurchaseWarrantsMember 2020-12-31 0001156784 COWI:TwoThousandTwentySevenToTwoThousandThirtySevenMember 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:GBP COWI:Segment utr:D utr:Y

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 


FORM S-1

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

 

 

 

CARBONMETA TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

  7349  

95-4868120

(State or other Jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

13110 NE 177th Place, Suite 145, Woodinville, WA 98072

(844) 698-3777

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

 

 

 

The Corporation Trust Company

Corporation Trust Center

1209 Orange St.

Wilmington, DE 19801

(302) 658-7581

 

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

 

Please send copies of all communications to:

 

Law Offices of Gary L. Blum

3278 Wilshire Boulevard, Suite 603

Los Angeles, CA 90010

(213) 381-7450

 

As soon as practicable after the effective date of this Registration Statement.

(Approximate date of commencement of proposed sale to the public)

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act of 1933, check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

Calculation of Registration Fee

 

Title of Each Class of

Securities To Be Registered

 

Amount to

be

Registered

(1)(2)(3)

   

Proposed
Maximum

Offering Price

Per Share (1)

   

Proposed
Maximum

Aggregate

Offering Price (4)

   

Amount of

Registration Fee (4)

 
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the March 7, 2022 Lloyd T. Spencer financing (the “March 2022 Spencer financing”)     435,000,000     $ 0.0005     $ 217,500     $ 20  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the March 21, 2022 Tangiers Investment Group, LLC financing (the “March 2022 Tangiers financing”)     375,000,000       0.0005       187,500       17  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the May 10, 2022 MacRab, LLC financing (the “May 2022 MacRab financing”)     226,130,000       0.0005       113,065       10  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the July 14, 2022 BHP Capital NY Inc. financing (the “July 2022 BHP financing”)     125,000,000       0.0005       62,500       6  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the July 14, 2022 Quick Capital, LLC financing (the “July 2022 Quick financing”)     125,000,000       0.0005       62,500       6  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the July 15, 2022 Robert Papiri Defined Benefit Plan. financing (the “July 2022 RPDBP financing”)     50,000,000       0.0005       25,000       2  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the July 15, 2022 Robert Papiri Defined Contribution Plan. financing (the “July 2022 RPDCP financing”)     12,500,000       0.0005       6,250       1  
Common stock, par value $.0001 per share, issuable upon conversion of a Convertible Promissory Note issued in connection with the July 15, 2022 RGP Capital Partners, Inc. financing (the “July 2022 RGP financing”)     12,500,000       0.0005       6,250       1  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the March 2022 Spencer financing     165,000,000       0.0005       82,500       8  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the March 2022 Tangiers financing     125,000,000       0.0005       62,500       6  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the May 2022 MacRab financing     74,375,000       0.0005       37,188       3  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the July 2022 BHP financing     62,500,000       0.0005       31,250       3  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the July 2022 Quick financing     62,500,000       0.0005       31,250       3  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the July 2022 RPDBP financing     25,000,000       0.0005       12,500       1  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the July 2022 RPDCP financing     6,250,000       0.0005       3,125       -  
Common stock, par value $.0001 per share, underlying a warrant issued in connection with the July 2022 RGP financing     6,250,000       0.0005       3,125       -  
Common stock, par value $.0001 per share, previously issued to selling shareholders     893,932,537       0.0005       446,966       41  
Total     2,781,937,537     $ -     $ 1,390,969     $ 129  

 

(1) The Offering price has been estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act and is based upon a $0.0005 per share price on the OTC Marketplace on July 25, 2022, the most recent day that the Registrant’s shares traded on the OTC Marketplace.
   
(2) Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.
   
(3) This Registration Statement covers the resale by our selling shareholders of up to 1,361,130,000 shares of common stock issuable upon conversion of convertible notes outstanding, 526,875,000 shares of common stock issuable upon exercise of warrants and 893,932,537 shares of common stock previously issued as Commitment shares
   
(4) Paid herewith. The fee is calculated by multiplying the aggregate offering amount by 0.0000927 pursuant to Section 6(b) of the Securities Act.

 

EXPLANATORY NOTE

 

Prior to the effectiveness of this Form S-1, we, “The Company”, are not subject to the periodic reporting requirements of the Exchange Act. We intend, with the filing of this Form S-1, and ultimate effectiveness of this Form S-1, to become SEC Reporting in which case we will be subject to comply with the periodic reporting requirements of the Exchange Act for so long as we are subject to those requirements.

 

 

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

  
 

 

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

PRELIMINARY PROSPECTUS - SUBJECT TO COMPLETION Dated July 29, 2022

 

CARBONMETA TECHNOLOGIES, INC.

 

2,781,937,537

Shares of

Common Stock

 

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”). This prospectus relates to the offering of up to 2,781,937,537 shares of our common stock, par value $0.0001 per share (“Common Stock”) by selling shareholders. This registration statement covers the resale by our selling shareholders of up to 893,932,537 shares of common stock previously issued to such selling shareholders, 526,875,000 shares of common stock issuable upon the exercise of multiple warrants and 1,361,130,000 shares of common stock issuable upon conversion of convertible notes. The information in this prospectus is not complete and may be changed. The selling shareholders may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. 

 

Our Common Stock is subject to quotation on OTC Markets “PINK” under the symbol “COWI.” On July 25, 2022, the last reported sales price for our Common Stock was $0.0005 per share. We urge prospective purchasers of our Common Stock to obtain current information about the market prices of our Common Stock. We will not receive proceeds from the sale of shares from the selling shareholders. We will, however, receive the exercise price of the warrants, if and when such warrants are exercised for cash by the holders of such warrants.

 

There are no underwriting commissions involved in this offering. We have agreed to pay all the costs and expenses of this offering. Selling shareholders will pay no offering expenses.

 

This offering is highly speculative and these securities involve a high degree of risk and should be considered only by persons who can afford the loss of their entire investment. Additionally, our auditor has expressed substantial doubt as to our Company’s ability to continue as a going concern. See “Risk Factors” beginning on page, 13.

 

Our Common Stock is quoted on the OTC Markets Pink under the symbol “COWI.”

 

Our common stock involves a high degree of risk. You should read the “RISK FACTORS” section beginning on page 13 before you decide to purchase any of our Common Stock.

 

The Company has minimal revenues to date and there can be no assurance that the Company will be successful in furthering its operations and/or revenues. Persons should not invest unless they can afford to lose their entire investment. Investing in our securities involves a high degree of risk. You should purchase these securities only if you can afford a complete loss of your investment. See “Risk Factors” beginning on page 13 of this prospectus.

 

Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

 

The date of this prospectus is July 29, 2022.

 

  
 

 

TABLE OF CONTENTS

 

PROSPECTUS SUMMARY 4
THE OFFERING 10
SUMMARY FINANCIAL DATA 12
RISK FACTORS 13
NOTE ABOUT FORWARD-LOOKING STATEMENTS 26
TAX CONSIDERATIONS 27
USE OF PROCEEDS 27
DILUTION 27
SELLING SHAREHOLDERS 27
DESCRIPTION OF SECURITIES 31
DIVIDEND POLICY 36
PROPERTIES 36
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION 36
DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, AND CONTROL PERSONS 42
EXECUTIVE COMPENSATION 43
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 45
MARKET FOR COMMON STOCK / SHARES ELIGIBLE FOR FUTURE SALE 47
WHERE YOU CAN FIND MORE INFORMATION 48
LEGAL PROCEEDINGS 48
EXPERTS 48
CORPORATE GOVERNANCE 49
FINANCIAL STATEMENTS 52

 

You should rely only on the information contained in this prospectus and any free writing prospectus prepared by us or on our behalf. We have not authorized anyone to provide you with different or additional information. If anyone provides you with different or additional information, you should not rely on it. The information in this prospectus is accurate only as of the date on the front of this prospectus. Our business, financial condition, results of operations and prospects may have changed since the date of this prospectus. This prospectus is not an offer or solicitation relating to the securities in any jurisdiction in which such an offer or solicitation relating to the securities is not authorized. You should not consider this prospectus to be an offer or solicitation relating to the securities if the person making the offer or solicitation is not qualified to do so, or if it is unlawful for you to receive such an offer or solicitation.

 

3

 

 

PROSPECTUS SUMMARY

 

This summary highlights certain information appearing elsewhere in this prospectus. This summary is not complete and does not contain all of the information you should consider prior to investing. After you read this summary, you should read and consider carefully the more detailed information and financial statements and related notes that we include in this prospectus, especially the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” If you invest in our securities, you are assuming a high degree of risk.

 

Unless we have indicated otherwise or the context otherwise requires, references in the prospectus to “CarbonMeta,” the “Company,” “we,” “us” and “our” or similar terms are to CarbonMeta Technologies, Inc.

 

DESCRIPTION OF BUSINESS

 

Overview

 

CarbonMeta Technologies, Inc. (f/k/a CoroWare, Inc.) (“CarbonMeta”, the “Company”, “we”, “us”, or “our”) is a publicly quoted company seeking to create value for its shareholders by seeking to acquire other operating entities for growth in return for shares of our common stock.

 

The Company was incorporated on July 8, 2001 under the laws of the State of Delaware as SRM Networks, Inc. In connection with the acquisition of Hy-Tech Computer Systems, Inc. on January 31, 2003, the Company changed its name to Hy-Tech Technology Group, Inc. In connection with the Agreement and Plan of Merger Robotics Workspace Technology, Inc., Innova Holdings, Inc. and the Company’s wholly owned subsidiary, RWT Acquisition, Inc., dated July 21, 2004, the Company’s named changed to Innova Holdings, Inc. Subsequently, on November 20, 2006, the Company changed its name to Innova Robotics and Automation, Inc., and then on April 23, 2008, the Company changed its name to CoroWare, Inc. On or about July 28, 2021, the Company filed Articles of Amendment to its Amended and Restated Certificate of Incorporation with the State of Delaware to reflect a name change from CoroWare, Inc. to CarbonMeta Technologies, Inc.

 

The Company has six wholly-owned subsidiaries: CoroWare Technologies, Inc. (“CTI”), CoroWare Robotics Solutions, Inc. (“CRS”), RWT Acquisition, Inc. (“RWT”), Carbon Sources, Inc. (“CS”), Coroware Treasury, Inc. (“CWT”), CarbonMeta Research Ltd. (‘CMR”) and a 51% interest in AriCon, LLC (“AriCon).

 

CoroWare Technologies (“CTI”) was incorporated in the State of Florida on May 16, 2006 and its principal business was a software professional services company with a strong focus on information technology integration and robotics integration, business automation solutions, and unmanned systems solutions to its customers in North America and Europe.

 

CoroWare Robotics Solutions, Inc. (“CRS”) was incorporated in the State of Texas on February 27, 2015, and its principal business was as a technology incubation company whose focus was on the delivery of mobile robotics and IOT products, solutions and services for university, government and corporate researchers, and enterprise customers. CRS’s business operations were discontinued in October 2016 when the Company’s gross margins and financing costs became unsustainable.

 

Robotic Workspace Technologies, Inc. (“RWT”) was incorporated in the State of Florida on July 1, 1994, and its principal business was developing and marketing open-architecture PC controls and related products that could improve the performance, applicability, and productivity of robots and other automated equipment. RWT’s business operations were discontinued in September 2007 when the Company’s losses became unsustainable.

 

Carbon Source, Inc. (“CS”) was incorporated in the State of Wyoming on June 14, 2021 and its principal business is waste reclamation technologies and processing.

 

CoroWare Treasury, Inc. (“CWT”) was incorporated in the State of Wyoming on July 6, 2021 and its principal business is acquisitions related to acquiring technologies and subsidiary businesses related to waste processing.

 

CarbonMeta Research Ltd. (‘CMR”) was incorporated in England and Wales on August 12, 2021 and its principal business will focus on the development of technologies and solutions for processing organic wastes and generating economically sustainable hydrogen and high-value carbon products.  Using proprietary and patented technologies, it plans to implement new industrial methods using inexpensive, environmentally friendly catalysts that process collected plastic waste material into high value products such as hydrogen gas, graphene and carbon nanotubes.

 

AriCon, LLC (“AriCon) was a joint venture that was intended to develop mobile robot platforms, applications, and solutions for the construction industry. In October 2016, AriCon ceased operations of all subsidiary business operations when the Company’s losses became unsustainable, and the Company was not able to obtain investment financing.

 

In 2021, the Company began investigating emerging technologies, strategic intellectual property partnerships, and sustainable growth business opportunities related to the production of hydrogen and high value carbon products from organic waste streams. Working cooperatively with Oxford University Innovation, CarbonMeta plans to implement proven and patented technologies to add value to organic waste streams. By utilizing these proven proprietary technologies, collected and captured plastic waste material can be upcycled to high value products such as carbon nanotubes (“CNTs”) and hydrogen gas.

 

CNTs can be used for improved electrical conduction and reinforcing materials that are used in a wide variety of industries including the automotive industry, aviation industry, medical industry, and construction. The number one growth driver is the increasing need for high performance batteries for the electric vehicle market.

 

The global hydrogen market is expected to more than double by the end of the decade. Plastic waste is a cheap and abundant feedstock that will allow the Company to scale quickly and produce hydrogen gas for a competitive price.

 

License Agreements

 

On June 2, 2021, the Company (the “Licensee”) entered into a License Agreement (the “Agreement”) with Oxford University Innovation Limited (the “Licensor”). Under the terms of the Agreement, the Licensee will license the licensed technology (OUI Project- Hydrogen from plastics via microwave-initiated catalytic dehydrogenation). The Agreement is non-exclusive and includes the United States and European Union. Signing fees for the Agreement are £54,807 and are due on August 2, 2021. The Royalty Rate is 5% of gross sales. The Agreement comprises milestone fees as: (i) £20,000 upon the first commercial sale of a licensed product; (ii) £50,000 upon generating $1,000,000 in sales; (iii) £10,000 upon the successful grant of the US patent; and (iv) £10,000 upon the successful grant of the EU patent.

 

On December 2, 2021, the Company (“Licensee”) entered into a License of Agreement (the “Agreement”) with Ecomena Limited (an entity located in the United Kingdom) (“Licensor”). Under the terms of the Agreement, the Licensee will license the Licensed Technology to recycle industrial byproduct into cement free pavers and mortars that are environmentally friendly and continuously absorb carbon dioxide. The signing fees payable to the Licensor under the Agreement are £20,000 cash (approximately $27,247 at February 17, 2022) which has not yet been paid by the Licensee, and 160,000,000 shares of the Company’s common stock, which was delivered to the Licensor on February 17, 2022. The royalty rate payable to the Licensor is 5% of product sales, subject to a minimum of £5000 per year for license years 1 and 2, £3000 for license year 3 and £1000 for license year 4 and each license year thereafter. The term of the Agreement is five years from December 2, 2021 to December 2, 2026. The Licensee may terminate the Agreement for any reason at any time provided it gives Licensor six (6) months written notice to terminate expiring after December 2, 2024. If requested by the Licensee, the Licensor shall agree to the Agreement continuing in force after December 2, 2026.

 

Production Agreement

 

On January 11, 2022, the Company entered into an Interim Joint Product Development and Sales Representation Agreement (the “Agreement”) with Salvum Corporation. Under the terms of the Agreement, the parties agree to work together to develop both CarbonMeta’s proprietary cementless paver products known as “Cementless Paver” and Salvum’s proprietary concrete alternative products known as “Earthcrete.”  During the Term, Salvum agrees to manufacture CarbonMeta’s proprietary cementless paver products known as “Cementless Paver”. CarbonMeta reserves the right to appoint other manufacturers of the products and/or to engage other sales representatives for CarbonMeta’s proprietary cementless paver products known as “Cementless Paver” outside the United States of America.

 

4

 

 

In order to further grow its business, the Company plans to:

 

  Develop and patent new microwave catalysis processes that can yield high value hydrogen and carbon products;
     
  Work closely with commercial building and solar farm general contractors that want to purchase “carbon negative” construction materials that can generate carbon credits;
     
  Acquire or develop patents that will help the Company generate royalty revenues with potential customers and partners, and protect the Company’s competitive position against potential competitors;
     
  Develop new proprietary and patented technologies to implement new industrial methods that can use inexpensive, environmentally friendly catalysts to process collected plastic waste material into high value products such as hydrogen gas, graphene and carbon nanotubes;
     
  seek out government programs in the United Kingdom, European Union and United States that encourage the development of high value production of hydrogen and high value carbon products from organic waste streams; and
     
  Attract investment funds who will actively work with the Company to achieve these goals and help the Company grow rapidly during the next 3 years.

 

Some potential merger/acquisition candidates have been identified and discussions initiated. These candidates are within the Company’s core business model, serving commercial properties, accretive to cash flow, and geographically favorable. While seeking to identify acquisition candidates, the Company seeks to identify target entities with a similar core business model or a model which naturally integrates with its own, and which are situated in opportunistic geographic locations.

 

We have unrestricted discretion in seeking and participating in a business opportunity, subject to the availability of such opportunities, economic conditions, and other factors.

 

The selection of a business opportunity in which to participate is complex and risky. Additionally, we have only limited resources and may find it difficult to locate good opportunities. There can be no assurance that we will be able to identify and acquire any business opportunity which will ultimately prove to be beneficial to us and our shareholders. We will select any potential business opportunity based on our management’s best business judgment.

 

Our activities are subject to several significant risks, which arise primarily as a result of the fact that we have no specific business and may acquire or participate in a business opportunity based on the decision of management, which potentially could act without the consent, vote, or approval of our shareholders. The risks faced by us are further increased as a result of its lack of resources and our inability to provide a prospective business opportunity with significant capital.

 

Licenses:

 

On June 2, 2021, the Company (the “Licensee”) entered into a License Agreement (the “Agreement”) with Oxford University Innovation Limited (the “Licensor”). Under the terms of the Agreement, the Licensee will license the licensed technology (OUI Project- Hydrogen from plastics via microwave-initiated catalytic dehydrogenation). The Agreement is non-exclusive and includes the United States and European Union. Signing fees for the Agreement are £54,807 and are due on August 2, 2021. The Royalty Rate is 5% of gross sales. The Agreement comprises milestone fees as: (i) £20,000 upon the first commercial sale of a licensed product; (ii) £50,000 upon generating $1,000,000 in sales; (iii) £10,000 upon the successful grant of the US patent; and (iv) £10,000 upon the successful grant of the EU patent.

 

On December 2, 2021, the Company (“Licensee”) entered into a License of Agreement (the “Agreement”) with Ecomena Limited (an entity located in the United Kingdom) (“Licensor”). Under the terms of the Agreement, the Licensee will license the Licensed Technology to recycle industrial byproduct into cement free pavers and mortars that are environmentally friendly and continuously absorb carbon dioxide. The signing fees payable to the Licensor under the Agreement are £20,000 cash (approximately $27,247 at February 17, 2022) which has not yet been paid by the Licensee, and 160,000,000 shares of the Company’s common stock, which was delivered to the Licensor on February 17, 2022. The royalty rate payable to the Licensor is 5% of product sales, subject to a minimum of £5000 per year for license years 1 and 2, £3000 for license year 3 and £1000 for license year 4 and each license year thereafter. The term of the Agreement is five years from December 2, 2021 to December 2, 2026. The Licensee may terminate the Agreement for any reason at any time provided it gives Licensor six (6) months written notice to terminate expiring after December 2, 2024. If requested by the Licensee, the Licensor shall agree to the Agreement continuing in force after December 2, 2026.

 

Patents/Trademarks:

 

We currently hold no patents or trademarks.

 

Research & Development

 

The Company will continue to engage in research and development expenses. These will consist primarily of salaries, and benefits for employees who are responsible for building new products as well as improving existing products. We will expense all of our research and development costs as they are incurred.

 

Compliance Expenses

 

Our company incurs annual expenses to comply with state corporate governance and business licensing requirements. We estimate these costs to be under $2,000 per year for the establishment of foreign corporations in other states that we plan to operate.

 

Labor and Other Supplies

 

We currently have one part time employee. We contract all labor for public company governance services, website development, accounting, legal and daily activities outside of management.

 

5

 

 

Principal Products or Services and Markets

 

The Company is in the business of developing and marketing technologies and solutions that can process organic and construction wastes into economically high-value and ecologically sustainable products.

 

The Company is partnering with a microwave reactor manufacturer in the United States to “scale up” the patented waste plastics microwave processes that the Company licensed from Oxford University Innovation, and with a university partner in the United States to separate, purify and characterize carbon nanotubes that the UK and US developers shall produce.

 

The principal products that the Company intends to market comprise:

 

amorphous carbon, graphite, nano-graphite, graphene, carbon nanotubes, and hydrogen
carbon-negative building products that help alleviate climate change by capturing carbon dioxide (CO2) for renewable energy projects

 

Seasonality

 

We do not expect any seasonality in our business.

 

Leases

 

The Company anticipates its most significant lease obligations will be classified as fixed assets that will be used in the normal course of its business. Some lease obligations may include renewal or purchase options, escalation clauses, restrictions, penalties or other obligations that we will consider in determining minimum lease payments. The leases will be classified as either operating leases or capital leases, as appropriate.

 

Governmental Regulation

 

Our operations are subject to certain foreign, federal, state and local regulatory requirements relating to environmental, waste management, and health and safety matters. We believe we operate in substantial compliance with all applicable requirements. However, material costs and liabilities may arise from these requirements or from new, modified or more stringent requirements. Material cost may rise due to additional manufacturing cost of raw or made parts with the application of new regulations. Our liabilities may also increase due to additional regulations imposed by foreign, federal, state and local regulatory requirements relating to environmental, waste management, and health and safety matters. In addition, our past, current and future operations and those of businesses we acquire, may give rise to claims of exposure by employees or the public or to other claims or liabilities relating to environmental, waste management or health and safety concerns.

 

Our markets can be positively or negatively impacted by the effects of governmental and regulatory matters. We are affected not only by energy policy, laws, regulations and incentives of governments in the markets into which we sell, but also by rules, regulations and costs imposed by utilities. Utility companies or governmental entities could place barriers on the installation of our product or the interconnection of the product with the electric grid. Further, utility companies may charge additional fees to customers who install on-site power generation, thereby reducing the electricity they take from the utility, or for having the capacity to use power from the grid for back-up or standby purposes. These types of restrictions, fees or charges could hamper the ability to install or effectively use our products or increase the cost to our potential customers for using our systems in the future. This could make our systems less desirable, thereby adversely affecting our revenue and profitability potential. In addition, utility rate reductions can make our products less competitive which would have a material adverse effect on our future operations. These costs, incentives and rules are not always the same as those faced by technologies with which we compete. Additionally, reduced emissions and higher fuel efficiency could help our future customers combat the effects of global warming. Accordingly, we may benefit from increased government regulations that impose tighter emission and fuel efficiency standards.

 

6

 

 

Environmental Regulation

 

Upon the establishment or acquisition of a materials processing business or a paver production service, the Company will become subject to federal, state or provincial and local environmental, health, safety and transportation laws and regulations. These laws and regulations are administered by the EPA, Environment Canada, and various other federal, state, provincial and local environmental, zoning, transportation, land use, health and safety agencies in the U.S., Canada and Europe Many of these agencies will examine our subsidiary operations to monitor compliance with these laws and regulations and have the power to enforce compliance, obtain injunctions or impose civil or criminal penalties in case of violations. Because the primary mission of our business is to collect, manage and recycle waste in an environmentally sound manner, a significant portion of our capital expenditures will be related, either directly or indirectly, to supporting the Company’s subsidiary operations as they relate to compliance with federal, state, provincial and local rules.

 

Competition

 

CarbonMeta is pursuing a business strategy that is similar to other companies, but we will be using proprietary and patented technologies that are unique in the industry. Nevertheless, there are many other companies that are already producing carbon nanotubes, including:

 

  Advanced Material Development
  Carbon Solutions, Inc.
  Cnano Technology.
  First Graphene
  Hyperion Catalysis
  Nanocyl S.A.
  NanoIntegris
  Raymor Nanotech
  Tuball

 

Our technologies may also allow us to compete with producers of grey, blue and green hydrogen gas. When utilizing electrical energy from sustainable sources, our hydrogen gas can be considered as green hydrogen and therefore sustainable.

 

As with the carbon nanotubes, there are many other companies that are already producing hydrogen gas, including:

 

  PowerTap Hydrogen Capital Corp
  Sunhydrogen Inc.
  Ways2H
  SGH2
  Standard Hydrogen Corp
  Powerhouse Energygroup
  Hydrogen Utopia International
  Japan Blue Energy
  Wabash Valley Resources
  Raven SR
  Bayotech
  Electro Active

 

Our potential competitors may have greater resources, better access to capital, longer histories, more intellectual property and lower cost operations.

 

They may secure better terms during the investment negotiation process, make strategic decisions more quickly than us and devote more capital to better performing investments than we do.

 

Our competitors may also enter into business combinations or alliances that strengthen their competitive positions.

 

Market opportunity

 

An estimated 8.3 billion metric tonnes of plastic waste have been generated to date, with a mere 9% of that volume being recycled, 12% incinerated and 79% going to landfills. In 2016, the world generated 242 million tonnes of plastic waste—12 percent of all municipal solid waste, according to The World Bank. This plastic waste primarily originated from three regions—57 million tonnes from East Asia and the Pacific, 45 million tonnes from Europe and Central Asia, and 35 million tonnes from North America.

 

Each year an additional 300 million tonnes of plastic waste are produced, which is projected to continue. According to the original study published in Science Advances, by 2050, there will be 12 billion metric tons of plastic in landfills.

 

Lack of proper waste management results in plastic waste reaching earth’s oceans. Several organizations are monitoring the abundance of plastic debris in rivers and oceans. Researchers, universities, and non-profit initiatives all conclude that plastic waste form a hazard for marine wildlife and should be captured, preferably before reaching earth’s oceans. Organizations such as The Ocean Cleanup are making great progress in capturing a portion of the plastic waste streams; however, processing this captured plastic is still a challenge.

 

Over the past few years, several organizations introduced methods to use plastic waste as a feedstock to produce high value materials. Some organizations offer plastic waste recycling solutions that transform unsorted, unwashed waste plastic into liquid fuels; however, these solutions do not address the worldwide objective of reducing greenhouse gas emissions.

 

The gasification of plastic waste for the synthetic gas (syngas) production is a widely used method to upcycle plastic waste. Several studies have shown that working under high temperatures are an important factor to obtain the gasses, as temperature affects the yield and the type of gasses obtained. A 2020 journal presented on the 6th International Conference on Energy and Environmental Research revealed the need for high temperatures, and more importantly it revealed that only a limited range of plastics could be used to generate high value synthetic gasses.

 

7

 

 

Pyrolysis is a common technique used to convert plastic and organic wastes into energy, in the form of solid, liquid, and gaseous fuels. Different catalysts are used to improve the pyrolysis process and improve efficiency. However, catalysts are expensive, thus making the overall process less profitable. Moreover, this process is also energy-intensive, and the resulting oil product requires additional energy to be further refined. Pyrolysis also requires emission treatment technologies since some gasses produced through this method are toxic.

 

Working cooperatively with university and industry partners, CarbonMeta Technologies plans to implement new industrial processes that selectively break carbon-hydrogen bonds in plastics waste using inexpensive, environmentally friendly iron-based catalysts to yield high purity hydrogen and high value carbons. Using these proven proprietary technologies, collected plastic waste material can be upcycled to high value products such as hydrogen gas, graphene and carbon nanotubes.

 

The global market for hydrogen currently stands at approximately 100 billion USD and is growing at a rate of 3-5% per annum. In addition, the market for hydrogen fuel cells is currently valued at 3 billion USD but is growing at 30-50% per annum.

 

According to Deloitte Consulting, hydrogen is projected to play a key role in the future of energy. Business leaders worldwide are moving their attention to creating a hydrogen infrastructure to benefit from the opportunities. Hydrogen is expected to be applied first in sectors that are under pressure to decarbonize, however current production methods to produce hydrogen on a large scale are not carbon neutral nor inexpensive. The demand for green hydrogen is growing as people recognize the potential. Plastic waste is a cheap and abundant feedstock that will allow the company to scale quickly and produce hydrogen gas for a competitive price.

 

The market for carbon products is approximately 30 billion USD, with a growth rate of over 20% in higher value segments. The Carbon Nanotube (CNT) market is estimated to grow up to USD 7 billion by 2026; the number one growth driver is the increasing need for high performance batteries for the electric vehicle market. Carbon Nanotubes can be used for improving electrical conduction and reinforcing materials used in the automotive, aviation, medical, and construction industries.

 

Growth Issues

 

Scalability

 

CarbonMeta has been and will continue to partner with leading edge materials research taking place at Oxford University and other universities that are developing unique solutions for processing organic waste into high value hydrogen and carbon products.

 

Insufficient Capital

 

Currently, CarbonMeta is confronted with the need to attract and retain a consistent investment source in order to grow our operations rapidly. If CarbonMeta is not funded properly, it will prevent us from capturing a significant portion of the market. To establish a first mover advantage in this space, CarbonMeta is seeking funding from the capital markets which may include debt and equity offerings.

 

Production Lead Time

 

We anticipate that the lead time for the development of our first patented solution that will be commercially operational will be 18 months. This reflects equipment ordering, installation, development, testing, operational readiness, and market readiness.

 

Marketing Strategy

 

CarbonMeta shall market its hydrogen and carbon products to industrial customers that are developing higher capacity electrochemical energy storage, and construction customers that are seeking higher strength concrete materials, and tire manufacturers that are developing lower-resistance and longer wear tires for automobiles and trucks.

 

CarbonMeta shall market its carbon nanotube products to industrial customers that are developing higher capacity electrochemical energy storage, and construction customers that are seeking higher strength concrete materials, and tire manufacturers that are developing lower-resistance and longer wear tires for automobiles and trucks. The Company will implement a direct sales and marketing strategy to reach potential customers and generate revenues.

 

Acquisition Interest

 

In implementing a structure for a particular business acquisition, we may become a party to a merger, consolidation, reorganization, joint venture, or licensing agreement with another company or entity. We may also acquire stock or assets of an existing business. Upon consummation of a transaction, it is probable that our present management and stockholders will no longer be in control of us. In addition, our sole director may, as part of the terms of the acquisition transaction, resign and be replaced by new directors without a vote of our stockholders, or sell his stock in us. Any such sale will only be made in compliance with the securities laws of the United States and any applicable state.

 

It is anticipated that any securities issued in any such reorganization would be issued in reliance upon exemption from registration under application federal and state securities laws. In some circumstances, as a negotiated element of the transaction, we may agree to register all or a part of such securities immediately after the transaction is consummated or at specified times thereafter. If such registration occurs, it will be undertaken by the surviving entity after it has successfully consummated a merger or acquisition and is no longer considered an inactive company.

 

The issuance of substantial additional securities and their potential sale into any trading market which may develop in our securities may have a depressive effect on the value of our securities in the future. There is no assurance that such a trading market will develop.

 

While the actual terms of a transaction cannot be predicted, it is expected that the parties to any business transaction will find it desirable to avoid the creation of a taxable event and thereby structure the business transaction in a so-called “tax-free” reorganization under Sections 368(a)(1) or 351 of the Internal Revenue Code (the “Code”). In order to obtain tax-free treatment under the Code, it may be necessary for the owner of the acquired business to own 80% or more of the voting stock of the surviving entity. In such event, our stockholders would retain less than 20% of the issued and outstanding shares of the surviving entity. This would result in significant dilution in the equity of our stockholders.

 

As part of our investigation, we expect to meet personally with management and key personnel, visit and inspect material facilities, obtain independent analysis of verification of certain information provided, check references of management and key personnel, and take other reasonable investigative measures, to the extent of our limited financial resources and management expertise. The manner in which we participate in an opportunity will depend on the nature of the opportunity, the respective needs and desires of both parties, and the management of the opportunity.

 

With respect to any merger or acquisition, and depending upon, among other things, the target company’s assets and liabilities, our stockholders will in all likelihood hold a substantially lesser percentage ownership interest in us following any merger or acquisition. The percentage ownership may be subject to significant reduction in the event we acquire a target company with assets and expectations of growth. Any merger or acquisition can be expected to have a significant dilutive effect on the percentage of shares held by our stockholders.

 

We will participate in a business opportunity only after the negotiation and execution of appropriate written business agreements. Although the terms of such agreements cannot be predicted, generally we anticipate that such agreements will (i) require specific representations and warranties by all of the parties; (ii) specify certain events of default; (iii) detail the terms of closing and the conditions which must be satisfied by each of the parties prior to and after such closing; (iv) outline the manner of bearing costs, including costs associated with the Company’s attorneys and accountants; (v) set forth remedies on defaults; and (vi) include miscellaneous other terms.

 

As stated above, we will not acquire or merge with any entity which cannot provide independent audited financial statements within a reasonable period of time after closing of the proposed transaction. If such audited financial statements are not available at closing, or within time parameters necessary to insure our compliance within the requirements of the 1934 Act, or if the audited financial statements provided do not conform to the representations made by that business to be acquired, the definitive closing documents will provide that the proposed transaction will be voidable, at the discretion of our present management. If such transaction is voided, the definitive closing documents will also contain a provision providing for reimbursement for our costs associated with the proposed transaction.

 

Employees

 

As of the date of this Report, we had one (1) part time employee that served as the Company’s sole officer and director. Our employee is not represented by a union. We consider relations with our employee to be positive and productive. We plan to expand our management team within the next 12 months to include certain officers for any acquisitions and any new subsidiaries or operational activities management deems necessary. We consider our relations with our employees and consultants to be in good standing. Please see DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, AND CONTROL PERSONS for additional information.

 

Report to Shareholders

 

The public may read and copy these reports, statements, or other information we file at the SEC’s public reference room at 100 F Street, NE., Washington, DC 20549 on official business days during the hours of 10 a.m. to 3 p.m. State that the public may obtain information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330. The Commission maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Commission at (http://www.sec.gov).

 

8

 

 

Going Concern

 

The Company had minimal revenues and has incurred losses of $65,453,925 from inception through the three months ended March 31, 2022 and negative working capital of $26,439,659 at March 31, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

There can be no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available from external sources such as debt or equity financings or other potential sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material adverse effect on its business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or that they will not have a significant dilutive effect on the Company’s existing stockholders.

 

The Company intends to overcome the circumstances that impact its ability to remain a going concern through a combination of the commencement of revenues, with interim cash flow deficiencies being addressed through additional equity and debt financing. The Company anticipates raising additional funds through public or private financing, strategic relationships or other arrangements in the near future to support its business operations; however, the Company may not have commitments from third parties for a sufficient amount of additional capital. The Company cannot be certain that any such financing will be available on acceptable terms, or at all, and its failure to raise capital when needed could limit its ability to continue its operations. The Company’s ability to obtain additional funding will determine its ability to continue as a going concern. Failure to secure additional financing in a timely manner and on favorable terms would have a material adverse effect on the Company’s financial performance, results of operations and stock price and require it to curtail or cease operations, sell off its assets, seek protection from its creditors through bankruptcy proceedings, or otherwise. Furthermore, additional equity financing may be dilutive to the holders of the Company’s common stock, and debt financing, if available, may involve restrictive covenants, and strategic relationships, if necessary, to raise additional funds, and may require that the Company relinquish valuable rights. Please see NOTE C – GOING CONCERN within the Company’s financial statement for the three months ended March 31, 2022 for further information.

 

Company Information

 

We are a Delaware corporation. Our corporate address is 20205 144th Ave NE, Woodinville, WA 98072, our telephone number is (844) 698-3777 and our website address is www.carbonmetatech.com. The information on our website is not a part of this prospectus. The Company’s stock is quoted under the symbol “COWI” on the OTC Markets “PINK.” The Company’s transfer agent is Empire Stock Transfer whose address is 1859 Whitney Mesa Dr., Henderson, NV, Tel: (702) 818-5898 Fax: (702) 974-1444.

 

9

 

 

Smaller Reporting Company

 

We also qualify as a “smaller reporting company” under Rule 12b-2 of the Exchange Act, which is defined as a company with a public equity float of less than $75 million. To the extent that we remain a smaller reporting company at such time as we are no longer an emerging growth company, we will still have reduced disclosure requirements for our public filings some of which are similar to those of an emerging growth company, including having to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and the reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.

 

THE OFFERING

 

Securities offered   Up to 2,781,937,537 shares of our Common Stock
     
Offering Amount   $1,393,969
     
Terms of the Offering   The Selling Shareholders will determine when and how they will sell the Common Stock offered in this Prospectus. The shares of our Common Stock may be offered and sold by Selling Shareholders at a fixed price of $0.0005 per share until our Common Stock is quoted on the OTC Markets “PINK”, and thereafter at prevailing market prices or privately negotiated prices or in transactions that are not in the public market.
     
Common Stock Issued and Outstanding Before This Offering   18,937,886,254 (1)
     
Common Stock Issued and Outstanding After This Offering  

 

20,825,891,254 (2)(3)(4)(5)(6)(7)(8)(9)

     
Risk Factors   See “Risk Factors” beginning on page 13 and the other information set forth in this prospectus for a discussion of factors you should consider before deciding to invest in our securities.
     
Market for Common Stock   Our Common Stock is subject to quotation on the OTC Markets “PINK” under the symbol “COWI.”
     
Dividends   We have not declared or paid any cash dividends on our common stock since our inception, and we do not anticipate paying any such dividends for the foreseeable future.

 

10

 

 

 

(1) The number of shares of our common stock outstanding before this Offering is 18,937,886,254 as of July 25, 2022.
   
(2)

On March 7, 2022, the Company received $66,000 from the Company Chief executive Officer Lloyd Spencer and issued to Lloyd T. Spencer (the “Holder”) a Promissory Note (the “Note”) in the principal amount of $66,000. The Note has a term of one (1) year (Maturity Date of March 7, 2023) and bears interest at 12% annually. The Holder shall have the right, on any calendar day, at any time on or following the Issue Date, to convert all or any portion of the then outstanding and unpaid Principal Amount and interest (including any Default Interest) into fully paid and non-assessable shares of Common Stock. The per share conversion price into which Principal Amount and interest (including any Default Interest) under this Note shall be convertible into shares of Common Stock hereunder (the “Conversion Price”) shall equal $0.0002. If at any time the Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock, then at the sole discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the Conversion Amount for such conversion may be increased to include Additional Principal, where “Additional Principal” means such additional amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares issuable upon such conversion to equal the same number of conversion shares as would have been issued had the Conversion Price not been adjusted by the Holder to the par value price. In conjunction with the financing transaction, the Company issued the Holder a five-year Common Stock Purchase Warrant granting the Holder the right to purchase 165,000,000 shares of common stock at an exercise price of $0.0002 per share and 33,000,000 shares of common stock. The transaction closed on March 7, 2022.

   
(3)

On March 21, 2022, the Company issued to Tangiers Investment Group, LLC (the “Holder”) a Promissory Note (the “Note”) in the principal amount of $55,000. The Note has a term of one (1) year (Maturity Date of March 21, 2023) and bears interest at 12% annually. The Holder shall have the right, on any calendar day, at any time on or following the Issue Date, to convert all or any portion of the then outstanding and unpaid Principal Amount and interest (including any Default Interest) into fully paid and non-assessable shares of Common Stock. The per share conversion price into which Principal Amount and interest (including any Default Interest) under this Note shall be convertible into shares of Common Stock hereunder (the “Conversion Price”) shall equal $0.0002. If at any time the Conversion Price as determined hereunder for any conversion would be less than the par value of the Common Stock, then at the sole discretion of the Holder, the Conversion Price hereunder may equal such par value for such conversion and the Conversion Amount for such conversion may be increased to include Additional Principal, where “Additional Principal” means such additional amount to be added to the Conversion Amount to the extent necessary to cause the number of conversion shares issuable upon such conversion to equal the same number of conversion shares as would have been issued had the Conversion Price not been adjusted by the Holder to the par value price. In conjunction with the financing transaction, the Company issued the Holder a five-year Common Stock Purchase Warrant granting the Holder the right to purchase 125,000,000 shares of common stock at an exercise price of $0.0004 per share and 27,500,000 shares of common stock as commitment shares. The transaction closed on March 21, 2022.

   
(4)

On May 10, 2022, the Company issued MacRab, LLC (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the amount of $33,056. The Note has a term of one (1) year (Maturity date of May 10, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this Note, the Holder was issued five-year warrants to purchase 74,375,000 shares of common stock at an exercise price of $0.0004 per share and 16,527,775 shares of common stock as commitment shares. The transaction closed on May 10, 2022.

   
(5)

On July 14, 2022, the Company issued BHP Capital NY, Inc. (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the principal amount of $25,000. The Note has a term of one (1) year (Maturity date of July 14, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this note, the Holder was issued five-year warrants to purchase 62,500,000 shares of the Company’s common stock at an exercise price of $0.0004. In addition, the Holder and the Company entered into a Registration Rights Agreement (“RRA”) whereby the Company agreed to register 212,500,000 shares of its common stock within 30 days of entry into the RRA for the benefit of the Holder. The transaction closed on July 18, 2022.

   
(6)

On July 14, 2022, the Company issued Quick Capital, LLC (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the principal amount of $25,000. The Note has a term of one (1) year (Maturity date of July 14, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this note, the Holder was issued five-year warrants to purchase 62,500,000 shares of the Company’s common stock at an exercise price of $0.0004. In addition, the Holder and the Company entered into a Registration Rights Agreement (“RRA”) whereby the Company agreed to register 212,500,000 shares of its common stock within 30 days of entry into the RRA for the benefit of the Holder. The transaction closed on July 18, 2022.

   
(7) On July 15, 2022, the Company issued the Robert Papiri Defined Benefit Plan (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the principal amount of $10,000. The Note has a term of one (1) year (Maturity date of July 15, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this note, the Holder was issued five-year warrants to purchase 25,000,000 shares of the Company’s common stock at an exercise price of $0.0004. In addition, the Holder and the Company entered into a Registration Rights Agreement (“RRA”) whereby the Company agreed to register 85,000,000 shares of its common stock within 30 days of entry into the RRA for the benefit of the Holder. The transaction closed on July 18, 2022.
   
(8) On July 15, 2022, the Company issued the Robert Papiri Defined Contribution Plan (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the principal amount of $2,500. The Note has a term of one (1) year (Maturity date of July 15, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this note, the Holder was issued five-year warrants to purchase 6,250,000 shares of the Company’s common stock at an exercise price of $0.0004. In addition, the Holder and the Company entered into a Registration Rights Agreement (“RRA”) whereby the Company agreed to register 21,250,000 shares of its common stock within 30 days of entry into the RRA for the benefit of the Holder. The transaction closed on July 18, 2022.
   
(9) On July 15, 2022, the Company issued the RGP Capital Partners, Inc. (the “Holder”) a Fixed Convertible Promissory Note (the “Note”) in the principal amount of $2,500. The Note has a term of one (1) year (Maturity date of July 15, 2023) and bears interest at 12% annually. The Note is convertible, in whole or in part, at any time and from time to time before maturity at the option of the Holder at the Fixed Conversion Price of $0.0002. Upon the event of default, the Note shall accrue interest at the rate equal to the lower of 16% per annum or the highest rate permitted by law. In connection with this note, the Holder was issued five-year warrants to purchase 6,250,000 shares of the Company’s common stock at an exercise price of $0.0004. In addition, the Holder and the Company entered into a Registration Rights Agreement (“RRA”) whereby the Company agreed to register 21,250,000 shares of its common stock within 30 days of entry into the RRA for the benefit of the Holder. The transaction closed on July 18, 2022.

 

11

 

 

SUMMARY FINANCIAL DATA

 

The following summary of our financial data should be read in conjunction with, and is qualified in its entirety by reference to, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements, appearing elsewhere in this prospectus.

 

Statements of Operations Data

 

   

For the three

months ended

March 31, 2022

   

For the

year-ended

December 31, 2021

   

For the

year-ended
December 31, 2020

 
Revenue   $ -     $ -     $ -  
Loss from operations   $ (257,514 )   $ (428,502 )   $ (150,000 )
Other (expenses) income   $ (792,023 )   $ 8,697,449     $ (11,579,741 )
Net (loss) income   $ (1,049,537 )   $ 8,268,947     $ (11,729,741 )

 

Balance Sheet Data

 

   

For the three

months ended

March 31, 2022

  

As of

December 31, 2021

  

As of

December 31, 2020

 
Cash   $ 52,198   $10,573   $- 
Total assets   $ 272,172   $

159,646

   $- 
Total liabilities   $

26,513,246

  $

26,046,833

   $

39,777,577

 
Total stockholders’ (deficiency)   $ (26,241,074 )  $(25,887,187)  $(39,777,577)

 

12

 

 

RISK FACTORS

 

An investment in our Common Stock involves a high degree of risk. You should carefully consider the following risk factors, together with the other information contained in this Offering Circular, before purchasing our Common Stock. Any of the following factors could harm our business, financial condition, results of operations or prospects, and could result in a partial or complete loss of your investment. Some statements in this Offering Circular, including statements in the following risk factors, constitute forward-looking statements. Please refer to the section entitled “Cautionary Statement Regarding Forward-Looking Statements”.

 

Risks Relating to Our Financial Condition

 

Our independent registered accounting firm has expressed concerns about our ability to continue as a going concern.

 

The report of our independent registered accounting firm expresses concern about our ability to continue as a going concern based on the absence of significant revenues, our significant losses from operations and our need for additional financing to fund all of our operations. It is not possible at this time for us to predict with assurance the potential success of our business. The revenue and income potential of our proposed business and operations are unknown. If we cannot continue as a viable entity, we may be unable to continue our operations and you may lose some or all of your investment in our common stock.

 

We have limited operational history in an emerging industry, making it difficult to accurately predict and forecast business operation.

 

As we have less than ten years of corporate operational history and have yet to generate revenue under our new business model, it is extremely difficult to make accurate predictions and forecasts on our finances. This is compounded by the fact that we operate in both the carbon nanotubes and hydrogen sectors, which is a rapidly transforming technological sector. There is no guarantee that we will properly execute our business model in either sector.

 

As a growing company, we have yet to achieve a profit and may not achieve a profit in the near future, if at all.

 

We have not yet produced a net profit and may not in the near future, if at all. While we expect our revenue to grow, we have not achieved profitability and cannot be certain that we will be able to sustain our current growth rate or realize sufficient revenue to achieve profitability. Further, many of our competitors in the field of carbon nanotubes and hydrogen technology have a significantly larger user base and revenue stream but have yet to achieve profitability. Our ability to continue as a going concern may be dependent upon raising capital from financing transactions, increasing revenue throughout the year and keeping operating expenses below our revenue levels in order to achieve positive cash flows, none of which can be assured.

 

We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.

 

We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new features and products or enhance our existing products, improve our operating infrastructure or acquire complementary businesses and technologies. Accordingly, we may need to engage in continued equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of our common stock. Any debt financing we secure in the future, could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be impaired, and our business may be harmed.

 

13

 

 

We expect our quarterly financial results to fluctuate.

 

We expect our net sales and operating results to vary significantly from quarter to quarter due to a number of factors, including changes in:

 

  Demand for our products; and
     
  Our ability to obtain and retain existing customers; and
     
  Our ability to develop our carbon nanotubes and hydrogen products; and
     
  General economic conditions, both domestically and in foreign markets; and
     
  Advertising and other marketing costs; and
     
  Costs of producing the carbon nanotubes and hydrogen; and
     
  Retaining key personnel
     
  Positive returns on our alternative investments.

 

As a result of the variability of these and other factors, our operating results in future quarters may be below the expectations of our stockholders.

 

Risks Relating to Our Business and Industry

 

The COVID-19 pandemic may materially and adversely affect our business and operations.

 

The impact on our business from the outbreak of the COVID-19 coronavirus is unknown at this time and difficult to predict. While vaccines are currently being administered in the United States and other countries throughout the world, at the current time the federal government and local states have instituted restrictions which could adversely affect the Company’s operations. The impact of COVID-19 has also created global supply chain challenges. These challenges create risk in the timing of delivery of kiosks and products. As outbreaks happen in certain areas of the supply chain it will create delays. Having redundancies in these areas to minimize timeline creep is not cost effective. Additionally, the impact of the COVID-19 pandemic on the global financial markets may reduce our ability to access capital, which could negatively impact our short-term and long-term liquidity. Other potential adverse effects of COVID-19 might include, for example, our ability to meet projected goals through the continued availability of our workforce; adverse impacts from new laws and regulations affecting our business or increased cyber risks and reliance on technology infrastructure to support our business and operations, including through remote-work protocols. The specific impact that COVID-19 could have on these risks remains uncertain.

 

We have a history of losses, and we may not become profitable in the future.

 

The company has incurred losses in all the years since formation. Most of these investments were made in product development, engineering and some sales expenses. We may incur similar net losses for the foreseeable future.

 

We expect to continue to make significant future expenditures related to the development and expansion of our business, including:

 

  investments in our research and development team and in the development of processing organic waste streams into higher value carbon and hydrogen products;
  investments in sales and marketing, including expanding our sales force, increasing our customer base, increasing market awareness of our platform and development of new technologies;
  expanding of our operations and infrastructure, including internationally; and
  hiring additional employees.

 

CarbonMeta is changing its industry direction and business model

 

It will take 12-18 months to establish a firm direction towards revenue and profitability. The company will need to build out a new corporate leadership team, identify additional acquisition opportunities, and continue to work on and evolve its long-term business plan. The company is also incurring costs associated with general administration, including legal, accounting and other expenses related to being a public company upon completion of this offering.

 

As a result of these increased expenses, we will have to generate and sustain increased revenue to be profitable in future periods. Further, in future periods, our revenue growth rate could decline, and we may not be able to generate sufficient revenue to offset higher costs and achieve or sustain profitability. If we fail to achieve, sustain or increase profitability, our business and operating results could be adversely affected.

 

14

 

 

We have no operating history, which makes it difficult to predict our future results of operations.

 

The company was inactive from November 2016 through June 2020, which limits our ability to forecast our future results of operations and subjects us to a number of uncertainties, including our ability to plan for and anticipate future growth. Our historical revenue growth should not be considered indicative of our future performance. Further, in future periods, our revenue growth could slow or our revenue could decline for a number of reasons, including slowing demand for our solutions, increasing competition, a decrease in the growth of our overall market, or our failure, for any reason, to continue to capitalize on growth opportunities. We have also encountered and will encounter risks and uncertainties frequently experienced by growing companies in rapidly changing industries, such as determining appropriate investments of our limited resources, competition from other companies, attracting and retaining customers, hiring, integrating, training and retaining skilled personnel,

 

Changing global economic conditions may adversely affect our industry, business and results of operations.

 

Our overall performance depends in part on worldwide economic conditions and trade relations with Asia, Europe and Latin America. These conditions could adversely affect our customers’ ability or willingness to purchase products and services and could adversely affect our operating results. In addition, companies that have competing products may reduce prices which could also reduce our average selling prices and harm our operating results.

 

If we experience significant fluctuations in our rate of anticipated growth and fail to balance our expenses with our revenue forecasts, our results could be harmed.

 

Due to the early stages of our business model, the unpredictability of new markets that we enter and unpredictability of future general economic and financial market conditions, we may not be able to accurately forecast our rate of growth. We plan our expense levels and investment on estimates of future revenue and future anticipated rate of growth. We may not be able to adjust our spending quickly enough if the addition of new subscriptions or the renewal rate for existing subscriptions falls short of our expectations.

 

As a result, we expect that our revenues, operating results and cash flows may fluctuate significantly on a quarterly basis. Our recent revenue growth rates may not be sustainable and may decline in the future. We believe that period-to-period comparisons of our revenues, operating results and cash flows may not be meaningful and should not be relied upon as an indication of future performance.

 

We may in the future be sued by third parties for alleged infringement of their proprietary rights.

 

The waste processing, carbon nanotube, and hydrogen production industries are characterized by the existence of a large number of patents, trademarks and copyrights and by frequent litigation based on allegations of infringement or other violations of intellectual property rights. The outcome of any litigation is inherently uncertain. Any intellectual property claims, with or without merit, could be time-consuming and expensive to resolve, could divert management attention from executing our business plan and could require us to change our technology, change our business practices and/or pay monetary damages or enter into short- or long-term royalty or licensing agreements which may not be available in the future at the same terms or at all. Any adverse determination related to intellectual property claims or litigation could be material to our net income or cash flows of a particular quarter or could otherwise adversely affect our operating results.

 

Our quarterly results can fluctuate and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially.

 

We may fail to meet or exceed the expectations of securities analysts or investors, and the market price of our common stock or the trading price of the notes could decline. Moreover, our stock price may be based on expectations of our future performance that may be unrealistic or that may not be met. Some of the important factors that may cause our revenues, operating results and cash flows to fluctuate from quarter to quarter include:

 

  our ability to retain and increase sales to existing customers, attract new customers and satisfy our customers’ requirements;
     
  the number of new employees added;
     
  changes in our pricing policies whether initiated by us or as a result of intense competition;
     
  the rate of expansion and productivity of our sales force;

 

15

 

 

  new product and service introductions by our competitors;
     
  our success in selling our products and services to large enterprises;
     
  general economic conditions could adversely affect either our customers’ ability or willingness to purchase additional subscriptions or upgrade their service, or delay a prospective customers’ purchasing decision, or reduce the value of new subscription contracts, or affect renewal rates, all of which could adversely affect our operating results;
     
  the timing of customer payments and payment defaults by customers;
     
  costs associated with acquisitions of companies and technologies;
     
  extraordinary expenses such as litigation or other dispute-related settlement payments; and
     
  the impact of new accounting pronouncements.

 

Many of these factors are not within our control, and the occurrence of one or more of them might cause our operating results to vary widely. As such, we believe that quarter-to-quarter comparisons of our revenues, operating results and cash flows may not be meaningful and should not be relied upon as an indication of future performance.

 

As we acquire companies or technologies in the future, they could prove difficult to integrate, disrupt our business, dilute stockholder value and adversely affect our operating results and the value of your investment.

 

As part of our business strategy, we regularly evaluate acquisitions of complementary businesses, joint ventures, services and technologies, and we expect that periodically we will continue to make such investments and acquisitions in the future. Acquisitions and investments involve numerous risks, including:

 

  the potential failure to achieve the expected benefits of the combination or acquisition;
     
  difficulties in and the cost of integrating operations, technologies, services and personnel;
     
  diversion of financial and managerial resources from existing operations;
     
  risk of entering new markets in which we have little or no experience;
     
  potential write-offs of acquired assets or investments;
     
  potential loss of key employees;
     
  inability to generate sufficient revenue to offset acquisition or investment costs;
     
  the inability to maintain relationships with customers and partners of the acquired business;
     
  potential unknown liabilities associated with the acquired businesses;
     
  unanticipated expenses related to acquired technology and its integration into existing technology;
     
  negative impact to our results of operations because of the depreciation and amortization of amounts related to acquired intangible assets, fixed assets and deferred compensation, and the loss of acquired deferred revenue;
     
  delays in customer purchases due to uncertainty;
     
  the need to implement controls, procedures and policies appropriate for a public company at companies that prior to the acquisition lacked such controls, procedures and policies; and
     
  challenges caused by distance, language and cultural differences.

 

16

 

 

In addition, if we finance acquisitions by issuing additional convertible debt or equity securities, our existing stockholders may be diluted which could affect the market price of our stock. Further, if we fail to properly evaluate and execute acquisitions or investments, our business and prospects may be seriously harmed, and the value of your investment may decline.

 

The market for carbon nanotubes and hydrogen are volatile, and if it develops more slowly than we expect, our business could be harmed.

 

The market for producing carbon nanotubes and hydrogen is not as mature as the market for packaged enterprise software and hardware, and it is uncertain whether these services will achieve and sustain high levels of demand and market acceptance. If enterprises do not perceive the benefits of carbon nanotubes and hydrogen, then the market for these products and services may not develop at all, or it may develop more slowly than we expect, either of which would significantly adversely affect our operating results. In addition, we may make errors in predicting and reacting to relevant business trends, which could harm our business.

 

Any failure to protect our intellectual property rights could impair our ability to protect our proprietary technology and our brand.

 

If we fail to protect our intellectual property rights adequately, our competitors might gain access to our technology, and our business might be harmed. In addition, defending our intellectual property rights might entail significant expense. Any of our trademarks or other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. While we plan to file patents, we may be unable to obtain patent protection for the technology covered in our patent applications. In addition, any patents issued in the future may not provide us with competitive advantages or may be successfully challenged by third parties. Furthermore, legal standards relating to the validity, enforceability and scope of protection of intellectual property rights are uncertain. Effective patent, trademark, copyright and trade secret protection may not be available to us in every country in which our service is available. The laws of some foreign countries may not be as protective of intellectual property rights as those in the U.S., and mechanisms for enforcement of intellectual property rights may be inadequate. Accordingly, despite our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our intellectual property.

 

We might be required to spend significant resources to monitor and protect our intellectual property rights. We may initiate claims or litigation against third parties for infringement of our proprietary rights or to establish the validity of our proprietary rights. Any litigation, whether or not it is resolved in our favor, could result in significant expense to us and divert the efforts of our technical and management personnel.

 

If we fail to develop our brands cost-effectively, our business may suffer.

 

We believe that developing and maintaining awareness of the Carbon Source brand and our other brands in a cost-effective manner is critical to achieving widespread acceptance of our existing and future services and is an important element in attracting new customers. Furthermore, we believe that the importance of brand recognition will increase as competition in our market develops. Successful promotion of our brands will depend largely on the effectiveness of our marketing efforts and on our ability to provide reliable secure and useful services at competitive prices. In the past, our efforts to build our brands have involved significant expense. Brand promotion activities may not yield increased revenue, and even if they do, any increased revenue may not offset the expenses we incurred in building our brands. If we fail to successfully promote and maintain our brands or incur substantial expenses in an unsuccessful attempt to promote and maintain our brands, we may fail to attract enough new customers or retain our existing customers to the extent necessary to realize a sufficient return on our brand-building efforts, and our business could suffer.

 

17

 

 

We are dependent on our management team and development and operations personnel, and the loss of one or more key employees or groups could harm our business and prevent us from implementing our business plan in a timely manner.

 

Our success depends substantially upon the continued services of our executive officers and other key members of management, particularly our Chief Executive Officer. From time to time, there may be changes in our executive management team resulting from the hiring or departure of executives. Such changes in our executive management team may be disruptive to our business. We are also substantially dependent on the continued service of our existing development and operations personnel because of the complexity of our service and technologies. We do not have employment agreements with any of our executive officers, key management, development or operations personnel and, therefore, they could terminate their employment with us at any time. We do not maintain key person life insurance policies on any of our employees. The loss of one or more of our key employees or groups could seriously harm our business.

 

Our sole officer and director holds similar positions at another public company

 

Mr. Spencer has been serving as a Director, President and Chief Executive Officer at CarbonMeta Technologies, Inc. (OTCPK:COWI) since November 2008 and currently serves as Secretary and Director of Deep Green Waste & Recycling, Inc. (OTCPK:DGWR).

 

We may not be successful in our efforts to build a pipeline of product candidates.

 

A key element of our strategy is to build a pipeline of carbon and hydrogen products that are marketable. Even if we are successful in building a product pipeline, the potential product candidates that we identify may not be suitable for sale to customers for any number of reasons. If our methods of identifying potential product candidates fail to produce a pipeline of potentially viable product candidates, then our success as a business will be dependent on the success of fewer potential product candidates, which introduces risks to our business model and potential limitations to any success we may achieve.

 

Because competition for our target employees is intense, we may not be able to attract and retain the highly skilled employees we need to support our operations and increasing customer base.

 

In the technology industry, there is substantial and continuous competition for engineers with high levels of experience in designing, developing and managing software and Internet-related services, as well as competition for sales executives and operations personnel. We may not be successful in attracting and retaining qualified personnel. We expect to experience difficulty in hiring and retaining highly skilled employees with appropriate qualifications. In addition, job candidates and existing employees often consider the value of the stock awards they receive in connection with their employment. If our stock price performs poorly, it may adversely affect our ability to retain highly skilled employees. In addition, since we expense all stock-based compensation, we may periodically change our stock compensation practices, which may include reducing the number of employees eligible for options or reducing the size of equity awards granted per employee. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and future growth prospects could be severely harmed.

 

If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.

 

We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.

 

We do not maintain workers’ compensation insurance to cover us for costs and expenses, that we may incur due to injuries to our employees resulting from the use of hazardous materials. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological or hazardous materials.

 

In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our discovery, preclinical development or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.

 

18

 

 

Our business is subject to changing regulations regarding corporate governance and public disclosure that have increased both our costs and the risk of non-compliance.

 

We are subject to rules and regulations by various governing bodies, including, for example, the Securities and Exchange Commission, which are charged with the protection of investors and the oversight of companies whose securities are publicly traded. Our efforts to comply with new and changing regulations have resulted in and are likely to continue to result in, increased general and administrative expenses and a diversion of management time and attention from revenue-generating activities to compliance activities.

 

Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, our business may be harmed.

 

Natural disasters and other events beyond our control could materially adversely affect us.

 

Natural disasters or other catastrophic events may cause damage or disruption to our operations, international commerce and the global economy, and thus could have a strong negative effect on us. Our business operations are subject to interruption by natural disasters, fire, power shortages, pandemics and other events beyond our control. Although we maintain crisis management and disaster response plans, such events could make it difficult or impossible for us to deliver our services to our customers and could decrease demand for our services.

 

We may be unable to manage growth, which may impact our potential profitability.

 

Successful implementation of our business strategy requires us to manage our growth. Growth could place an increasing strain on our management and financial resources. To manage growth effectively, we will need to:

 

  Establish definitive business strategies, goals and objectives;
     
  Maintain a system of management controls; and
     
  Attract and retain qualified personnel, as well as, develop, train and manage management-level and other employees.

 

If we fail to manage our growth effectively, our business, financial condition or operating results could be materially harmed, and our stock price may decline.

 

We may not be able to compete successfully with other established companies offering the same or similar services and, as a result, we may not achieve our projected revenue and user targets.

 

If we are unable to compete successfully with other businesses in our existing market, we may not achieve our projected revenue and/or targets. We compete with both start-up and established financial and technology companies. Compared to our business, some of our competitors may have greater financial and other resources, have been in business longer, have greater name recognition and be better established in the carbon nanotubes and hydrogen sectors.

 

19

 

 

Failure to manage our rapid growth effectively could increase our expenses, decrease our revenue, and prevent us from implementing our business strategy.

 

After funding, we expect to experience a period of rapid growth. To manage our anticipated future growth effectively, we must continue to maintain, and may need to enhance, our information technology infrastructure and financial and accounting systems and controls, as well as manage expanded operations in geographically distributed locations. We also must attract, train, and retain a significant number of qualified sales and marketing personnel, professional services personnel, software engineers, technical personnel, and management personnel. Failure to manage our rapid growth effectively could lead us to over-invest or under-invest in technology and operations; result in weaknesses in our infrastructure, systems, or controls; give rise to operational mistakes, losses, or loss of productivity or business opportunities; and result in loss of employees and reduced productivity of remaining employees. Our growth could require significant capital expenditures and may divert financial resources and management attention from other projects, such as the development of new services. If our management is unable to effectively manage our growth, our expenses may increase more than expected, our revenue could decline or may grow more slowly than expected, and we may be unable to implement our business strategy.

 

We depend on key employees and face competition in hiring and retaining qualified employees.

 

Our employees are vital to our success, and our key management and other employees are difficult to replace. We may not be able to retain highly qualified employees in the future which could adversely affect our business.

 

Our lack of adequate D&O insurance may also make it difficult for us to retain and attract talented and skilled directors and officers.

 

We may in the future be subject to additional litigation, including potential class action and stockholder derivative actions. Risks associated with legal liability are difficult to assess and quantify, and their existence and magnitude can remain unknown for significant periods of time. To date, we have not obtained directors and officers liability (“D&O”) insurance. While neither Delaware law nor our Articles of Incorporation or Bylaws require us to indemnify or advance expenses to our officers and directors involved in such a legal action, we have entered into an indemnification agreement with our President and intend to enter into similar agreements with other officers and directors in the future. Without adequate D&O insurance, the amounts we would pay to indemnify our officers and directors should they be subject to legal action based on their service to the Company could have a material adverse effect on our financial condition, results of operations and liquidity. Furthermore, our lack of adequate D&O insurance may make it difficult for us to retain and attract talented and skilled directors and officers, which could adversely affect our business.

 

We may experience significant losses from operations.

 

Even if we do generate operating income in one or more quarters in the future, subsequent developments in our industry, customer base, business or cost structure or an event such as significant litigation or a significant transaction may cause us to again experience operating losses. We may not become profitable for the long-term, or even for any quarter.

 

Because competition for our target employees is intense, we may not be able to attract and retain the highly skilled employees we need to support our planned growth.

 

To continue to execute on our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for senior sales executives and engineers with high levels of experience in designing and developing software and Internet-related services. We may not be successful in attracting and retaining qualified personnel. We have from time to time in the past experienced, and we expect to continue to experience in the future, difficulty in hiring and retaining highly skilled employees with appropriate qualifications. Many of the companies with which we compete for experienced personnel have greater resources than we have. In addition, in making employment decisions, particularly in the Internet and high-technology industries, job candidates often consider the value of the equity awards they are to receive in connection with their employment. Volatility in the price of our stock or failure to obtain stockholder approval for increases in the number of shares available for grant under our equity plans may, therefore, adversely affect our ability to attract or retain key employees. Furthermore, the requirements to expense equity awards may discourage us from granting the size or type of equity awards that job candidates require to join our company. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and future growth prospects could be severely harmed.

 

20

 

 

We may fail to realize the anticipated benefits of any acquisition.

 

The success of any acquisition will depend on, among other things, our ability to combine our businesses in a manner that does not materially disrupt existing relationships and that allows us to achieve operational synergies and capitalize on the increased brand recognition and customer base of the combined company. If we are not able to achieve these objectives, the anticipated benefits of the acquisition may not be realized fully or at all or may take longer to realize than expected. In particular, the acquisition may not be accretive or accelerate sales in near or long term.

 

The integration process could result in the loss of key employees; the disruption of our ongoing businesses; or inconsistencies in standards, controls, procedures, or policies that could adversely affect our ability to maintain relationships with third parties and employees or to achieve the anticipated benefits of the acquisition. Integration efforts between the two companies will also divert management’s attention from our core business and other opportunities that could have been beneficial to our shareholders. An inability to realize the full extent of, or any of, the anticipated benefits of the acquisition, as well as any delays encountered in the integration process, could have an adverse effect on our business and results of operations, which may affect the value of the shares of our common stock after the completion of the acquisition.

 

Further, the actual integration may result in additional and unforeseen expenses. Operational improvements and actual cost synergies, if achieved at all, may be lower than we expect and may take longer to achieve than we anticipate. If we are not able to adequately address these challenges, we may be unable to realize the anticipated benefits of the integration of any acquisition.

 

21

 

 

General Business Risks

 

Our business and operations may experience rapid growth. If we fail to manage our growth, our business and operating results could be harmed and we may have to incur significant expenditures to address the additional operational and control requirements of this growth.

 

We may experience rapid growth in our sales and operations, which may place significant demands on our management, operational and financial infrastructure. If we do not manage our growth, the quality of our products and services could suffer, which could negatively affect our brand and operating results. To manage this growth, we will need to continue to improve our operational, financial and management controls and our reporting systems and procedures. These systems enhancements and improvements will require significant capital expenditures and allocation of valuable management resources. If the improvements are not implemented successfully, our ability to manage our growth will be impaired and we may have to make significant additional expenditures to address these issues, which could harm our financial position. The required improvements may include: Enhancing our information and communication systems to attempt to optimize proper service to our customers, and Enhancing systems of internal controls to ensure timely and accurate reporting of all of our operations

 

If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results or prevent fraud. As a result, current and potential stockholders could lose confidence in our financial reporting, which would harm our business and the trading price of our stock.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, our brand and operating results could be harmed. We may in the future discover areas of our internal controls that need improvement. We cannot be certain that any measures we implement will ensure that we achieve and maintain adequate controls over our financial processes and reporting in the future. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to meet our reporting obligations. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.

 

We have no operating history under our new business model utilizing carbon nanotubes or hydrogen technology in an emerging and rapidly evolving market. This makes it difficult to evaluate our future prospects and may increase the risk that we will not be successful.

 

We have no operating history under our new business model utilizing carbon nanotubes or hydrogen technology. You must consider our business and prospects in light of the risks and difficulties we will encounter as an early-stage company in a new and rapidly evolving market. We may not be able to successfully address these risks and difficulties, which could materially harm our business and operating results.

 

We cannot be certain that additional financing will be available on reasonable terms when required, or at all.

 

From time to time, we may need additional financing. Our ability to obtain additional financing, if and when required, will depend on investor demand, our operating performance, the condition of the capital markets, and other factors. We cannot assure you that additional financing will be available to us on favorable terms when required, or at all. We may need to raise additional funds through the issuance of equity, equity-linked or debt securities, those securities may have rights, preferences, or privileges senior to the rights of our Common Stock, and our existing stockholders may experience dilution.

 

22

 

 

Rapid technological changes.

 

The industries in which the Company intends to compete with are subject to rapid technological changes. No assurances can be given that the technological advantages which may be enjoyed by the Company in respect of their technologies cannot or will not be overcome by technological advances in the respective industries rendering the Company’s technologies obsolete or non-competitive.

 

Lack of indications of product acceptability.

 

The success of the Company will be dependent upon its ability to develop commercially acceptable products and to sell such products in quantities sufficient to yield profitable results. To date, the Company has received no indications of the commercial acceptability of any of its proposed products. Accordingly, the Company cannot predict whether its products can be marketed and sold in a commercial manner.

 

Reliance upon third parties.

 

The Company does not intend on maintaining a significant technical staff nor does it intend on manufacturing its products. Rather it will rely heavily on consultants, contractors, and manufacturers to design, develop and manufacture its products. Accordingly, there is no assurance that such third parties will be available when needed at affordable prices.

 

Protection of intellectual property.

 

The success of the Company will be dependent, in part, upon the protection of its various proprietary technologies from competitive use. Certain of its technologies are the subject of various patents in varying jurisdictions. In addition to the patent applications, the Company relies on a combination of trade secrets, nondisclosure agreements and other contractual provisions to protect its intellectual property rights. Nevertheless, these measures may be inadequate to safeguard the Company’s underlying technologies. If these measures do not protect the intellectual property rights, third parties could use the Company’s technologies, and its ability to compete in the market would be reduced significantly.

 

In the future, the Company may be required to protect or enforce its patents and patent rights through patent litigation against third parties, such as infringement suits or interference proceedings. These lawsuits could be expensive, take significant time, and could divert management’s attention from other business concerns. These actions could put the Company’s patents at risk of being invalidated or interpreted narrowly, and any patent applications at risk of not issuing. In defense of any such action, these third parties may assert claims against the Company. The Company cannot provide any assurance that it will have sufficient funds to vigorously prosecute any patent litigation, that it will prevail in any of these suits, or that the damages or other remedies awarded, if any, will be commercially valuable. During the course of these suits, there may be public announcements of the results of hearings, motions and other interim proceedings or developments in the litigation, which could result in the negative perception by investors, which could cause the price of the Company’s common stock to decline dramatically.

 

Risks Related to this Offering

 

We are a shell company pursuant to Rule 405 of the Securities Act. This may impact our ability to attract additional capital.

 

We have limited assets, and our operations appear to have been primarily organizational since we discontinued previous operations in 2016. We are a shell company pursuant to Rule 405 of the Securities Act. The consequences of shell company status may affect our ability attract additional capital. Under SEC Rule 144 restricted and control securities may be resold in reliance on Rule 144 unless and until the company has ceased to be a shell company, is subject to the reporting requirements of section 13 or 15(d) of the Exchange Act, has filed all reports and other materials required to be filed by section 13 or 15(d) of the Exchange Act, during the preceding 12 months and has filed current “Form 10 information” with the SEC reflecting its status as an entity. When these conditions are satisfied, then those securities may be sold subject to the requirements Rule 144 after one year has elapsed from the date that the issuer filed “Form 10 information” with the SEC.

 

The unavailability of Rule 144 may affect our ability to attract additional capital as investors may not be willing to purchase restricted or control securities unless they can sell under Rule 144.

 

23

 

 

The market price of our Common Stock may fluctuate, and you could lose all or part of your investment.

 

The offering price for our Common Stock will be set by us based on a number of factors and may not be indicative of prices that will prevail on OTC Markets “PINK” or elsewhere following this Offering. The price of our Common Stock may decline following this Offering. The stock market in general, and the market price of our Common Stock will likely be subject to fluctuation, whether due to, or irrespective of, our operating results, financial condition and prospects.

 

Our financial performance, our industry’s overall performance, changing consumer preferences, technologies and advertiser requirements, government regulatory action, tax laws and market conditions in general could have a significant impact on the future market price of our Common Stock. Some of the other factors that could negatively affect our share price or result in fluctuations in our share price include:

 

  actual or anticipated variations in our periodic operating results;
     
  changes in earnings estimates;
     
  changes in market valuations of similar companies;
     
  actions or announcements by our competitors;
     
  adverse market reaction to any increased indebtedness we may incur in the future;
     
  additions or departures of key personnel;
     
  actions by stockholders;
     
  speculation in the press or investment community; and
     
  our intentions and ability to list our Common Stock on a national securities exchange and our subsequent ability to maintain such listing.

 

We do not expect to declare or pay dividends in the foreseeable future.

 

We do not expect to declare or pay dividends in the foreseeable future, as we anticipate that we will invest future earnings in the development and growth of our business. Therefore, holders of our Common Stock will not receive any return on their investment unless they sell their securities, and holders may be unable to sell their securities on favorable terms or at all.

 

Because we do not have an audit or compensation committee, shareholders will have to rely on our directors, none of whom is not independent, to perform these functions.

 

We do not have an audit or compensation committee comprised of an independent director. Indeed, we do not have any audit or compensation committee. The Board of Directors performs these functions as a whole. No members of the Board of Directors are an independent director. Thus, there is a potential conflict in that board members who are also part of management will participate in discussions concerning management compensation and audit issues that may affect management decisions.

 

Because we lack certain internal controls over financial reporting in that we do not have an audit committee and our Board of Directors has no technical knowledge of U.S. GAAP and internal control of financial reporting and relies upon the Company’s financial personnel to advise the Board on such matters, we are subject to increased risk related to financial statement disclosures.

 

We lack certain internal controls over financial reporting in that we do not have an audit committee and our Board of Directors has no technical knowledge of U.S. GAAP and internal control of financial reporting and relies upon the Company’s financial personnel to advise the Board on such matters. Accordingly, we are subject to increased risk related to financial statement disclosures.

 

Our sole officer and director holds a significant percentage of our outstanding voting securities, which could reduce the ability of minority shareholders to effect certain corporate actions.

 

Our sole officer and director, Lloyd Spencer, is the beneficial owner of 552,177,763 shares of common stock, 60,000 shares of Series D Preferred Stock and 25,000 shares of Series G Preferred Stock, which controls 90% of the voting securities prior to the Offering and 83% of our outstanding voting securities after the Offering, assuming all 2,781,937,537 shares of common stock in this Offering are sold. Mr. Spencer is the owner of 100% of the Company’s issued and outstanding Series G Preferred stock. The Company’s Series G Preferred stock has voting rights equal to 5,000,000 votes per each one share. As such, Mr. Spencer has voting rights equal to 125,000,000,000 shares of common stock and thus control of any item brought before shareholders requiring a vote. As a result of this ownership, Mr. Spencer possesses and can continue to possess significant influence and can elect and can continue to elect a majority of our Board of Directors and authorize or prevent proposed significant corporate transactions. Mr. Spencer’s ownership and control may also have the effect of delaying or preventing a future change in control, impeding a merger, consolidation, takeover or other business combination or discourage a potential acquirer from making a tender offer.

 

Upon completion of this offering, we will be subject to the current and periodic reporting requirements.

 

Upon the effectiveness of this registration statement, we will be subject to the periodic and current reporting requirements required by Section 13(a) of the Exchange Act, and any amendments thereof.

 

24

 

 

The preparation of our consolidated financial statements involves the use of estimates, judgments and assumptions, and our consolidated financial statements may be materially affected if such estimates, judgments or assumptions prove to be inaccurate.

 

Financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) typically require the use of estimates, judgments and assumptions that affect the reported amounts. Often, different estimates, judgments and assumptions could reasonably be used that would have a material effect on such financial statements, and changes in these estimates, judgments and assumptions may occur from period to period over time. Significant areas of accounting requiring the application of management’s judgment include, but are not limited to, determining the fair value of assets and the timing and amount of cash flows from assets. These estimates, judgments and assumptions are inherently uncertain and, if our estimates were to prove to be wrong, we would face the risk that charges to income or other financial statement changes or adjustments would be required. Any such charges or changes could harm our business, including our financial condition and results of operations and the price of our securities. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for a discussion of the accounting estimates, judgments and assumptions that we believe are the most critical to an understanding of our consolidated financial statements and our business.

 

If securities industry analysts do not publish research reports on us, or publish unfavorable reports on us, then the market price and market trading volume of our Common Stock could be negatively affected.

 

Any trading market for our Common Stock will be influenced in part by any research reports that securities industry analysts publish about us. We do not currently have and may never obtain research coverage by securities industry analysts. If no securities industry analysts commence coverage of us, the market price and market trading volume of our Common Stock could be negatively affected. In the event we are covered by analysts, and one or more of such analysts downgrade our securities, or otherwise reports on us unfavorably, or discontinues coverage or us, the market price and market trading volume of our Common Stock could be negatively affected.

 

Future issuances of our Common Stock or securities convertible into our Common Stock, or the expiration of lock-up agreements that restrict the issuance of new Common Stock or the trading of outstanding stock, could cause the market price of our Common Stock to decline and would result in the dilution of your shareholding.

 

Future issuances of our Common Stock or securities convertible into our Common Stock, and/or conversion of the Notes convertible into Common Stock, or the expiration of lock-up agreements that restrict the sale of Common Stock by selling shareholders, or the trading of outstanding stock, could cause the market price of our Common Stock to decline. We cannot predict the effect, if any, of the exercise of conversion of the Notes into Common Stock or other future issuances of our Common Stock or securities convertible into our Common Stock, or the future expirations of lock-up agreements, on the price of our Common Stock. In all events, future issuances of our Common Stock would result in the dilution of your shareholding. In addition, the perception that locked-up parties will sell their securities when the lock-ups expire, could adversely affect the market price of our Common Stock.

 

Our shares are subject to the penny stock rules, making it more difficult to trade our shares.

 

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If the price of our Common Stock is less than $5.00, our Common Stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our Common Stock, and therefore stockholders may have difficulty selling their shares.

 

25

 

 

NOTE ABOUT FORWARD-LOOKING STATEMENTS

 

Statements under “Prospectus Summary,” “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Description of Business” and elsewhere in this prospectus may be “forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements include, among other things, statements regarding:

 

  our ability to scale up the microwave catalysis processes that reportedly work in a laboratory setting;
     
  our ability to reliably source the materials from our supply chain partners in order to supply EarthCrete Cementless Concrete mix to our customers;
     
  our ability to attract enough investment in order to properly finance the capital and operational expenses needed to establish the business;
     
  our ability to apply for an win significant government grants that will help the Company compete well in a rapidly growing marketplace;
     
  our ability to identify government regulations and spending bills that can help the Company compete;
     
  our ability to identify joint ventures and strategic business relationships;
     
  our ability to carefully manage our cost of revenues, development expenses, sales and marketing expenses, and general and administrative expenses;

 

26

 

 

as well as other statements regarding our future operations, financial condition and prospects, and business strategies. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in this registration statement, of which this prospectus is a part, including the risks described under “Risk Factors.” Any forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances that occur in the future.

 

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we may have projected. Any forward-looking statements you read in this prospectus reflect our current views with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, financial condition, growth strategy and liquidity. You should specifically consider the factors identified in this prospectus that could cause actual results to differ before making an investment decision. In addition, as discussed in “Risk Factors,” our shares may be considered a “penny stock” and, as a result, the safe harbors provided for forward-looking statements made by a public company that files reports under the federal securities laws may not be available to us.

 

TAX CONSIDERATIONS

 

We are not providing any tax advice as to the acquisition, holding or disposition of the securities offered herein. In making an investment decision, investors are strongly encouraged to consult their own tax advisor to determine the U.S. Federal, state and any applicable foreign tax consequences relating to their investment in our securities.

 

USE OF PROCEEDS

 

This prospectus relates to shares of our common stock that may be offered and sold from time to time by the selling stockholders. We will not receive any proceeds from the sale of shares of common stock in this offering, except from the issuance of 74,375,000 shares of our common stock underlying the warrant issued to MacRab, LLC, 165,000,000 shares of our common stock underlying the warrant issued to Lloyd Spencer, 125,000,000 shares of our common stock underlying the warrants issued to Tangiers Investment Group, LLC 62,500,000 shares of our common stock underlying the warrants issued to BHP Capital NY Inc., 62,500,000 shares of our common stock underlying the warrants issued to Quick Capital, LLC, 25,000,000 shares of our common stock underlying the warrant issued to the Robert Papiri Defined Benefit Plan, 6,250,000 shares of our common stock underlying the warrant issued to the Robert Papiri Defined Contribution Plan, and 6,250,000 shares of our common stock underlying the warrant issued to RGP Capital Partners, Inc.

 

DETERMINATION OF OFFERING PRICE

 

The pricing of the Shares has been arbitrarily determined and established by the Company. No independent accountant or appraiser has been retained to protect the interest of the investors. No assurance can be made that the offering price is in fact reflective of the underlying value of the Shares. Each prospective investor is urged to consult with his or her counsel and/or accountant as to offering price and the terms and conditions of the Shares. Factors to be considered in determining the price include the amount of capital expected to be required, the market for securities of entities in a new business venture, projected rates of return expected by prospective investors of speculative investments, the Company’s prospects for success and prices of similar entities.

 

DILUTION

 

Not applicable. We are not offering any shares in this registration statement. All shares are being registered on behalf of our selling shareholders.

 

SELLING SHAREHOLDERS

 

This prospectus covers the resale from time to time by the selling shareholders and future shareholders identified in the table below of up to 2,781,937,537 shares of our common stock, which were issued in various transactions exempt from registration under the Securities Act, as follows:

 

  828,932,537 of the shares registered hereby for resale are common stock previously issued to such selling shareholders;
     
  435,000,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to Lloyd Spencer, the Company’s sole officer and director, on March 7, 2022. Please see NOTE H – CONVERTIBLE DEBT within the Company’s financial statement for the three months ended March 31, 2022 for additional information;
     
  165,000,000 of the shares registered hereby are issuable upon the exercise of the warrant issued to Lloyd Spencer on March 7, 2022. Please see NOTE H – CONVERTIBLE DEBT within the Company’s financial statement for the three months ended March 31, 2022 for additional information;
     
  375,000,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to Tangiers Investment Group, LLC on March 21, 2022. Please see NOTE H – CONVERTIBLE DEBT within the Company’s financial statement for the three months ended March 31, 2022 for additional information;
     
  125,000,000 of the shares registered hereby are issuable upon the exercise of the warrant issued to Tangiers Investment Group, LLC on March 21, 2022;
     
  226,130,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to MacRab, LLC on May 10, 2022;
     
  74,375,000 of the shares registered hereby are issuable upon the exercise of the warrant issued to MacRab, LLC on May 10, 2022;
     
  125,000,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to BHP Capital NY Inc. on July 14, 2022;
     
  62,500,000 of the shares registered hereby are issuable upon the exercise of the warrant issued to BHP Capital NY Inc. on July 14, 2022;
     
  125,000,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to Quick Capital, LLC on July 14, 2022;
     
  62,500,000 of the shares registered hereby are issuable upon the exercise of the warrant issued to Quick Capital, LLC on July 14, 2022;
     
  50,000,000 of the shares registered hereby are issuable upon conversion of the Convertible Note, which we sold to the Robert Papiri Defined Benefit Plan on July 15, 2022;